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Abstract 
 
Telomeres are the chromosome end structures consisting of telomere-associated 
proteins and short tandem repeat sequences, TTAGGG, in humans and mice. Telomeres 
prevent chromosome termini from being recognized as broken DNA ends. The structural 
integrity of DNA including telomeres is constantly threatened by a variety of DNA 
damaging agents on a daily basis. To counteract the constant threats from DNA damage, 
organisms have developed a number of DNA repair pathways to ensure that the integrity 
of genome remains intact. A number of DNA repair proteins localize to telomeres and 
contribute to telomere maintenance; however, it is still unclear as to what extent.  
Telomere shortening has been linked to rare human disorders that present with 
bone marrow failure including Fanconi anemia (FA). FANCC is one of the most 
commonly mutated FA genes in FA patients and the FANCC subtype tends to have a 
relatively early onset of bone marrow failure and hematologic malignancies. Here, we 
studied the role of Fancc in telomere length regulation in mice. We demonstrated that 
deletion of Fancc did not affect telomerase activity, telomere length or telomeric end-
capping in mice with long telomeres. We also showed that Fancc deficiency accelerates 
telomere shortening during high turnover of hematopoietic cells and promotes telomere 
recombination initiated by short telomeres. 
Telomere shortening has also been linked to human aging and cancer 
development, with oxidative stress as a major contributing factor. 8-oxo-7, 8-
dihydroguanine is among the most common oxidative DNA lesions, and is substrates for 
OGG1-initiated DNA base excision repair. Mammalian telomeres consist of triple 
guanine repeats and are subject to oxidative guanine damage. Here, we investigated the 
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impact of oxidative guanine damage and its repair by OGG1 on telomere integrity. We 
demonstrated that oxidative guanine damage can arise in telomeres where it affects length 
homeostasis, recombination, DNA replication, and DNA breakage repair. We also 
examined if telomeric DNA is particularly susceptible to oxidative guanine damage and if 
telomere specific factors affect the incision of oxidized guanines by OGG1. We showed 
that the GGG sequence context of telomere repeats and certain telomere configurations 
may contribute to telomere vulnerability to oxidative DNA damage processing. 
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All eukaryotic linear chromosomes consist of nucleoprotein complexes called 
telomeres. Telomeres are composed of extended tracts of short G-rich tandem repeat 
sequences, 5’-TTAGGG-3’, and short terminal single-stranded DNA 3’-overhangs in 
both humans and mice (1,2). This nucleoprotein complex includes telomere-specific 
binding proteins and their associated proteins (Fig. 1.1). It has been widely accepted that 
one of the main functions of telomeres is to prevent the ends of linear chromosomes from 
being recognized as broken DNA ends, thus protecting the cells from unwarranted double 
strand break (DSB) DNA repairs (e.g. non-homologous end-joining (NHEJ) or 
homologous recombination (HR)) (3). On the other hand, dysfunctional telomeres, 
emanating from loss of telomere repeats or loss of protection by telomere-associated 
proteins, can trigger a DNA damage response and subsequently lead to genome 
instability, cell proliferation defects, and cell death(4). To date, a number of human 
diseases and premature aging syndromes are frequently associated with telomere 
shortenings (5-7). This chapter will summarize the advancements made in the telomere 
field in recent years and discuss the significance of telomere maintenance in genome 
stability, cancer and aging in mammals. 
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Figure 1.1 – The Shelterin Complex  
The proposed assembly of shelterin complex is illustrated; six core members associate with telomeric DNA 
either directly or indirectly through protein-protein interactions 
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1.2 Shaping and Protecting the Human Telomeres – the Shelterin Complex  
To date, a number of proteins have been found to localize at telomeres; however, 
only six have been identified as components of the shelterin complex in humans and mice. 
These include telomere repeat binding factor 1 (TRF1), telomere repeat binding factor 2 
(TRF2), TRF interacting protein 2 (TIN2), repressor activator protein (RAP1), 
adrenocortical dysplasia homolog (TPP1), and protection of telomeres 1 (POT1) (Fig. 
1.1). They meet the conditions, as described in a recent review article, to be components 
of the shelterin complex, whereas the non-shelterin proteins found at telomeres often fail 
to meet the following criteria. “Shelterin is abundant at chromosome ends but does not 
accumulate elsewhere; it is present at telomeres throughout the cell cycle, and its known 
function is limited to telomeres” (3). The complex is assumed to consist of six core 
members; recent attempts to expand the list of shelterin complex via mass spectrometry 
have failed to add additional members (8,9). Shelterin-like complexes are also found in 
other eukaryotes, which suggest that the complex is functionally conserved (10-13). 
The functional significance of the shelterin complex depends, in part, on its 
components to directly bind and associate with telomeric DNA. However, not all 
members of the complex share this feature; only three out of the six components TRF1, 
TRF2 and POT1 are able to directly bind to telomeric DNA, whereas RAP1, TPP1, and 
TIN2 associate with telomere through protein-protein interactions as shown in Figure 1.1. 
TRF1 and TRF2 directly bind to double-stranded telomeric DNA as homodimers and 
serve as the basis of the complex (14,15).  TIN2 plays an important role by forming a 
bridge between TPP1/POT1 to TRF1 and TRF2, connecting them together (8,16,17). 
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RAP1 associates with the telomere through TRF2 (18,19). Interestingly, POT1 not only 
associates with telomeres by directly binding to single-stranded telomeric DNA, but it 
can also associate by interacting with TRF1 or TRF2 through TPP1 (16,20,21).  
When members of the shelterin complex were gradually identified and 
characterized, it was anticipated that shelterin complex provides protection at telomeres. 
Evidence now indicates that such protection occurs through members of the shelterin 
complex modulating/shaping the telomere’s unique landscape in three ways: the t-loop 
formation, generation and protection of 3’-overhang, and maintenance of the telomere 
length. T-loop formation was initially discovered by analyzing purified telomeric DNA 
using electron-microscopy-based analysis (22). Briefly, the t-loop is generated by 
allowing single-stranded telomeric DNA of the 3’-end of the G-strand to displace the 
upstream G-strand and then base pair with the C-strand creating a displacement loop or 
D-loop, which creates a circular structure where the 3’-end of the telomeric DNA is 
safely tucked in (Fig. 1.2). Interestingly, the size of this circular loop varies from 1kb to 
25kb in human cells, suggesting that the size of the structure is not functionally 
significant (3). Studies show that TRF1 and TRF2 may be involved in the formation of 
the t-loop since they are able to bend and modify telomeric DNA into different 
formations in vitro (15,23-25). However, it is anticipated that other shelterin proteins may 
also participate in the formation of the t-loop since TRF1’s ability to generate t-loop in 
vitro was inefficient and addition of TIN2 seemed to increase this ability (26,27). It is 
also plausible that non-shelterin proteins found at telomeres (e.g. WRN, BLM, and MRN 
complex) may participate in the formation of the t-loop (3).  
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Figure 1.2 – The t-loop formation  
T-loop structure is formed via strand invasion of 3’-overhang that displaces the G-strand, creating a D-loop. 
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The generation of the t-loop relies on strand invasion of 3’ end of G-strand, which 
requires invading strand to be single-stranded. Studies suggest that the shelterin complex 
may also have a hand in shaping this part of the telomere. For instance, TRF2 has been 
shown to protect the junction between double-stranded and single-stranded telomeric 
DNA by binding and blocking the cleaving of the 3’-overhang of G-strand by 
ERCC1/XPF, a 3’ flap endonuclease, and MRE11 nuclease, a part of MRN complex. It is 
hypothesized that safely-tucked in t-loops can also indirectly protect the 3’-overhang by 
blocking the access of nucleases (28-30). In addition, inhibition of POT1 results in a 
significant reduction of single-stranded 3’-overhang of G-strands in human cells, thus it 
is speculated that single-stranded 3’-overhang is protected from nucleolytic degradation 
via the binding of POT1 (31-33). POT1 is also implicated in the generation of 3’-
overhang. Briefly, as a result of leading strand DNA synthesis, telomere blunt ends may 
require nucleolytic processing on the newly synthesized daughter strand (3). It is 
hypothesized that POT1, which prefers to occupy the 3’-overhang just two nucleotides 
from the junction of double-stranded telomeric DNA, may simply block the 5’ 
exonuclease from further processing the terminal structure (3,31,34). However, the 
nuclease responsible for the processing of 5’ strand is still unclear. 
The maintenance of telomere length has proven to be a dynamic process in which 
cooperation between the members of shelterin complex and telomerase, a reverse 
transcriptase responsible for telomere extension (covered in next section), dictates the 
outcome. Briefly, it was demonstrated that shelterin proteins can either inhibit or promote 
(negative or positive feedback loops, respectively) the access of telomerase to telomeric 
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DNA. In terms of negative regulation, long telomeres most likely trigger a cis-acting 
mechanism that inhibits the access of telomerase since a large quantity of shelterin is 
available at telomeres (35). In contrast, short telomeres trigger the relaxation of this 
inhibition mechanism imposed by shelterin at telomeres; this is most likely due to limited 
quantity of telomeric DNA available for shelterin proteins to bind (Fig. 1.3). A mutant 
version of POT1, which can not bind to single-stranded telomeric DNA, caused 
extremely long telomeres, possibly as a result of its inability to inhibit the telomerase 
accessing telomeric DNA (36,37). Additional studies demonstrating a similar effect in 
TRF1, TRF2 and RAP1 further supports the view that the shelterin complex has a role in 
controlling the length of telomere (38,39). 
In eukaryotes, disruption of the t-loop and subsequent exposure of the 3’-
overhang (telomere uncapping) can lead to destabilized telomeres. Consequently, 
destabilized telomeres (dysfunctional or uncapped telomeres) are known to elicit DNA 
damage response pathways since the “capped” telomere normally inhibits such events 
from taking place (3,4). For instance, introduction of a dominant-negative form of TRF2 
inhibits the binding of endogenous TRF2 to telomeric DNA by heterodimerizing with the 
endogenous protein (28); this results in the activation of ATM kinase pathway and the 
subsequent up-regulation of p53-dependent and p21-mediated G1/S arrest (40-42). 
Furthermore, when other shelterin components POT1 and TIN2 were inhibited or the 
length of telomeres is shortened, DNA damage response markers such as 53BP1, γ-
H2AX, MRN complex, and ATM-Ser-1981-P accumulate at telomeres and form a 
structure now known as the Telomere dysfunction Induced Foci (TIF) (26,31,43). Studies 
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Figure 1.3 – The telomere length regulation via shelterin 
The accessibility of telomerase to telomeric DNA depends on the amount of shelterin proteins available at 
telomeres.
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using ATM-deficient cells and caffeine, inhibitors of ATM and other PI3-like kinases, 
lead to a decrease in TIF formation, which suggest that DNA damage response at the 
telomere is dependent on ATM and PI3-like kinase pathways (43). However, it is still 
unclear how functional telomeres prevent ATM activation at telomeres. It is thought that 
TRF2 can directly interact with ATM and inhibit its phosphorylation at serine-1981, 
which is required for its activation (44,45).Overall, it appears that DNA damage response 
at telomeres is a general damage response that is not specific to telomeres. 
Aided by the shelterin complex, functional telomeres not only protect the ends of 
linear chromosomes from DNA damage response but also from undesirable 
recombination repairs such as nonhomologous end-joining (NHEJ) and homologous 
recombination (HR). These repairs are known to create problems at telomeres. For 
instance, NHEJ between two ends of telomere causes abnormal chromosome end-to-end 
fusions resulting in a circular or a dicentric chromosome. These events could lead to 
chromosome segregation defects during cell division, thus forming a characteristic 
chromatin bridge of dicentric chromosome in anaphase cells;  this could result in 
chromosome breakage or cytokinetic failure leading to aneuploidy and eventually 
apoptosis or cancer (Fig. 1.4A) (4). The shelterin components (e.g. TRF2 and POT1) 
protect telomeres from aberrant NHEJ since a lack of function results in fusion between 
two telomeres (31,33). More over, critically short telomeres (i.e. uncapped telomeres) can 
trigger NHEJ at telomere ends (4). Interestingly, the 3’ overhang poses an obstacle to 
telomeric NHEJ since the process requires two blunt ends.  In mammals, ERCC1/XPF 
endonuclease is implicated in removing the 3’ overhang in telomeres before NHEJ 
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Figure 1.4 – DNA repairs such as NHEJ and HR can create havoc to telomere integrity  
A) Chromosome end-to-end fusion from NHEJ could result in aneuploidy. B) HR between two sister 
chromatids through T-SCE could have severe consequences as a result. C) T-loop HR could shorten 
telomeric DNA by truncating the circular part of t-loop. 
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machinery can fuse the two telomeres (29). However, the events leading up to 
recruitment of nucleases and activation of NHEJ is still unclear. Nonetheless, it is thought 
that functional telomeres prevent NHEJ through t-loop formation since its circular 
structure can hide the 3’ ends from being accessible to ERCC1/XPF endonuclease that 
NHEJ machinery depends on (3,41).  
Telomeric homologous recombination is another aberrant repair that is known to 
be detrimental; it can lead to abnormal telomere length and collapse of the t-loop. For 
instance, branch migration of the t-loop toward the centromere can result in double 
holiday-junction and if the resulting structure is resolved by crossover, the entire loop 
segment can be lost, leaving critically shorten telomeres (Fig. 1.4C) (46). The shelterin 
protein TRF2 protects telomeres from such events since a loss of function results in 
sudden truncation of telomeres and appearance of circular extrachromosomal telomeric 
DNA (47,48). Further examination revealed that these truncations were dependent on 
proteins implicated in HR, the MRN complex and XRCC3, a protein involved in holiday-
junction resolution (49). However, an exact mechanism of TRF2 suppressing the t-loop 
HR is not well understood. The telomere sister chromatid exchange (T-SCE) is another 
telomere-specific recombination event, in which one of the sister chromatids maintains its 
telomere length by using the other as a template (50). Thus, if the length of two sister 
chromatids were different, one could be lengthened at the expense of the other, risking 
the possibilities of acquiring critically short telomeres via HR (Fig. 1.4B) (51). These two 
HR events are closely related since relaxation of repression can be observed in alternative 
lengthening of telomere (ALT) cells (52), suggesting that tight control of telomeric HR is 
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strictly enforced via shelterin complex under normal circumstances; thus strengthening 
the importance of the shelterin complexes’ role in providing protection of telomeres. 
 
1.3 Telomere Length Regulation – Telomerase or Alternative Lengthening of 
Telomere (ALT) 
In living organisms, DNA is replicated in a “semi conservative” fashion where the 
complementary strands are synthesized using each parental strand as a template. This 
process is mainly carried out by DNA polymerase enzymes which are only able to 
synthesize DNA in the 5’ to 3’ direction. In cells with linear chromosomes, the leading 
strand can be replicated in a continuous manner, whereas the lagging strand is replicated 
in a discontinuous manner by the use of Okazaki fragments. The Okazaki fragment 
typically cannot bind to the very tip of the 3’ end of lagging strand for further replication, 
which means that chromosomes will gradually get shorter after each successive round of 
DNA replication (Fig. 1.5A). This is known as the “end-replication problem” which 
could compromise the integrity of the genome due to loss of genetic information at the 
end part of the chromosomes (53). Eukaryotic cells have evolved to counteract the “end-
replication problem” by using telomeres as a buffer zone and extending it through the 
enzyme telomerase. Telomerase is ribonucleoprotein complex composed of telomere 
reverse transcriptase, TERT, with its own RNA molecule, TERC, and dyskerin. The 
template region of TERC is 3'-CAAUCCCAAUC-5', which telomerase uses to extend 
new telomeric DNA repeat (5'-GGTTAG-3') sequence by using the first few nucleotides 
of the template at the 3’ end of the leading strand (Fig. 1.5B). As discussed in Section 1.2, 
 
- 13 - 
 
 
Figure 1.5 – Telomere length regulation via Telomerase 
A) The end-replication problem; inability to replicate part of the lagging strand could lead to genetic 
information loss at the ends of linear chromosomes. B) Telomeres are elongated by telomerase, a 
holoenzyme which consist of a reverse transcriptase (TERT) and RNA molecule (TERC).
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the members of shelterin complex and telomerase collaborate through carefully 
choreographed cis/trans mechanism to ensure that the telomere length is maintained 
above a critical level (54). 
L. Hayflick made an observation that human fibroblasts, when cultured, had a life 
span of ~50 population doublings before succumbing to cellular senescence. This 
phenomenon is widely known as the Hayflick limits. It was later discovered that adult 
stem cells and somatic cells, such as primary fibroblasts, lack the ability to regenerate 
telomeric DNA since they either have low or no telomerase activity, therefore 
contributing to cellular senescence. However, not all cell types share this characteristic; 
germ cells have high telomerase activity, and are thus believed to go on dividing for the 
lifetime of the organism. In addition, another class of cells that has high telomerase 
activity and have unlimited potential to divide are cancer cells. Most cancer cells are 
known to reactivate telomerase, which is an important feature of the cellular 
immortalization process (55). Indeed, there is a technique used to immortalize primary 
cells involves transfecting them with telomerase; thus demonstrating that telomerase 
activity and maintenance of telomere length allow for long term cellular survival (56). 
This suggests that cellular immortalization has high correlation with reactivation of the 
telomerase enzyme, and prior studies have also shown that about 85-90% of all cancers 
have active telomerase (57). Interestingly, about 10-15% of all cancers do not have active 
telomerase (57), and studies have shown that these cells utilize a mechanism known as 
the alternative lengthening of telomere (ALT) to maintain their telomere length (58).  
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The initial discovery of ALT was made when human cell lines, without any 
noticeable telomerase activity, were found that are able to uncharacteristically maintain 
their telomere length over many cell divisions (59). These ALT cells have a unique set of 
phenotypic characteristics different from that of telomerase positive cells (52). One of the 
most important features of ALT cells is that they have long and heterogeneous telomeric 
DNA ranging from 2kb to 50kb in length along with few ends with a little or no visible 
telomeric DNA, also known as the telomere signal free ends (60). Furthermore, ALT-
associated promeylotic leukemia nuclear bodies (APBs) are often found in ALT cells. 
These APBs can be easily identified using a standard indirect immunofluorescence 
technique since they contain extrachromosomal telomeric DNA in both linear or circular 
form (termed t-circles), shelterin proteins (i.e. TRF1 and TRF2), PML protein, and DNA 
repair proteins (46,61-63). It has been suggested that one of APB’s function is to act as a 
garbage collector for extrachromosomal telomeric DNA to prevent unnecessary DNA 
damage responses (61). Also, there is evidence suggesting that APBs are the sites of ALT 
activity. The frequency of APB-positive cells is much higher during G2 phase when ALT 
is thought to take place; HR, a key mechanism in ALT, is also most active during this 
phase (64,65). Interestingly, not all ALT cells share these unique phenotypic 
characteristics since some ALT cell lines without telomerase were shown to lack some of 
these characteristics (58); therefore it is still unclear how these phenotypic characteristics 
are associated to the ALT mechanism. 
A number of studies suggest that ALT cells maintain their telomere length 
through a HR-dependent mechanism. For instance, ALT cells characteristically have 
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increased levels of two different types of telomere-specific HR events when compared to 
non-ALT cells; HR-dependent telomeric DNA replication and post-replicative T-SCE 
(Fig. 1.6) (66). Earliest evidence to support the occurrence of HR-dependent telomeric 
DNA replication in ALT cells was uncovered by performing recombinational telomere 
extension (RTE). Briefly, when a DNA tag was inserted within telomeric DNA repeats, 
ALT cells were able to duplicate the tags into other telomeres whereas no duplication was 
made in telomerase-positive cells; it failed to duplicate in a sub-telomeric region when 
subjected to similar treatment (67). Although an exact mechanism is not established, 
studies indicate adjacent telomeres in addition to extrachromosomal telomeric DNA (i.e. 
linear and t-circles) can be used as a template in HR-dependent telomere replication in 
ALT cells (66). Accumulating evidence demonstrates that there is significant increase in 
the frequency of T-SCE in ALT cells compared to non-ALT cells. Simultaneously, there 
is no significant increase in the rate of recombination frequencies at the genomic regions 
in ALT cells as compared to non-ALT cells, which indicates that increased 
recombination events in ALT cells are telomere-specific (68,69). The mechanism behind 
T-SCE is still unclear. It is thought that repair of a broken replication fork at telomere can 
initiate telomeric-HR, thus leading to T-SCE (66). 
The relationship between proteins involved in HR-dependent telomere 
maintenance and ALT-related activities remains to be a complex issue. It appears to 
require the usual proteins involved in functional telomere maintenance (66). To date, only 
two protein complexes, MRN and SMC5/6, have been shown to participate in telomere 
length maintenance in ALT cells; inhibition of these proteins led to significant reduction 
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Figure 1.6 – HR-dependent telomere maintenance in ALT cells 
A) HR-dependent DNA replication. B) T-loop resolution C) Telomere recombination via T-SCE. 
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in amount of APB-positive cells (70,71). The accumulation of shelterin and its associated 
proteins in APB also suggest that they are involved in ALT activity but it is still unclear 
as to what extent. How the ALT mechanism is suppressed and/or initiated and which 
proteins are involved is still being debated, however, it has been considered that a loss of 
protection by the shelterin complex could serve as one of the possible starting points as 
discussed in Section 1.2.  
 
1.4 Telomeres and Disease 
As discussed in Section 1.3, somatic and adult stem cells have little or no 
telomerase activity as compared to germ cells, and, as a result, this eventually leads to 
progressive telomere shortening with age. Depending on the cell type, short telomeres 
could ultimately contribute to cellular senescence (fibroblast) and apoptosis (epithelial), 
which can be detrimental to an organism’s well-being (42). In fact, short telomeres are 
frequently observed in a number of late stage cancers, premature ageing syndromes and 
human diseases that are associated with ageing (72-74). For instance, human diseases of 
various origins that are associated with ageing, such as heart disease, liver cirrhosis and 
atherosclerosis are characterized as having short telomeres when compared to healthy 
individuals (75-77). In addition, a correlation between the risk of death from heart disease 
and telomere length has been recently demonstrated (78). Taken together, these 
observations suggest that there is a correlation between telomere length maintenance and 
the manifestation of human diseases associated with short telomeres. However, it is still 
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unknown if the diseases are caused by short telomeres or accelerated telomere attrition is 
the result of the disease itself. 
A number of human premature ageing syndromes have been instrumental in 
providing our current knowledge of telomere loss and its consequence due to their 
accelerated rate of telomere shortening with age. One such syndrome is dyskeratosis 
congenita (DC). It is a rare but genetically diverse and age-associated disease that is 
frequently identified by the triad of classical symptoms of dysplastic nails, oral 
leukoplaskia and hyperpigmentation of skin. DC is the quintesential form of the inherited 
bone marrow failure syndrome (IBMFS) that represents a clinical consequence of short 
telomeres, many cases of disease exhibit mutations in the shelterin component, TIN2, or 
the components of telomerase: Tert, Terc, or dyskeratosis congenita 1 (DKC1) genes. 
Mutations in any one of these genes in telomerase have shown to reduce telomerase 
activity and result in accelerated telomere loss along with elevated incidence of 
chromosomal instabilities in DC patients (79,80). Additionally, other forms of IBMFS 
such as acquired aplastic anemia (AA) and idiopathic pulmonary fibrosis (IPF) have also 
been shown to possess mutations in the telomerase components, resulting in accelerated 
telomere attrition and ultimately premature death (81,82). In contrast, however, a number 
of human premature ageing syndromes associated with accelerated telomere loss and 
chromosomal instability do not have mutations in genes encoding the telomerase 
complex. Instead, these syndromes have mutations in genes that encode DNA repair 
proteins, e.g., Nbs1 (Nijmegen breakage syndrome), Mre11 (Ataxia telangiectasia–like 
disorder), WRN (Werner syndrome), BLM (Bloom syndrome), ATM (Ataxia 
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telangiectasia) and proteins encoded by FANC (Fanconi anemia complementation group 
proteins) genes. However, many of these proteins are known to play a role at telomeres, 
thus may contribute to telomere length maintenance (83). 
Ever since the practice of employing a knock-out mouse model has been 
popularized, it has become instrumental in examining gene functions in the context of the 
whole organism. The telomerase knock-out model, generated by eliminating the mouse 
Terc or Tert genes, has helped in illustrating the consequence of aberrant telomere length 
maintenance (84-87). Studies indicate that the telomerase-deficient mouse model is 
characterized with atrophies of various tissues and a loss of long-term viability where 
only a limited number of generations can be obtained (88-91). More importantly, the 
phenotypes of the telomerase knock-out model emulate some of pathologies illustrated in 
age-related human diseases and premature ageing syndromes (92). For instance, recent 
studies have shown that the telomerase knock-out mouse model partially showed 
symptoms similar to DC patients, such as short stature, infertility, premature death, and, 
most importantly, defective hematopoietic system and bone marrow defect. Interestingly, 
DC patients have increased occurrences of spontaneous cancer, whereas Terc-deficient 
mice showed elevated resistance to cancer. A possible rationale for this difference could 
be that some DC patients still have intact telomerase function which could be 
unexpectedly up-regulated during tumorigenesis; Terc-deficient mice have no telomerase 
activity (92-94). The phenotype discrepancy between knock-out mouse model and its 
representative human disease extends to other age-related diseases with short telomeres. 
For instance, fanconi anaemia (FA) mouse models have normal telomeres and do not 
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fully reproduce the human disease phenotype (95). Similarly, knock-out mouse models 
for human premature ageing syndromes such as BLM and WRN do not emulate the full-
blown human manifestation of the disease and, more importantly, do not reproduce 
premature ageing pathologies (96,97).  
Inbred mice have unusually longer telomeres and higher telomerase activities than 
humans. Therefore, it is believed that some human-disease mouse models’ inability to 
manifest the pathological phenotypes is probably due to lack of critically short telomeres. 
In agreement with this idea, mouse-model deficient in Terc and some DNA repair genes 
show an acceleration of the ageing phenotypes. For instance, Werner, Bloom and ATM 
mouse models in conjunction with telomerase deficiency featured some pathological 
phenotypes observed in human patients (98-100). This demonstrates that short telomeres 
contribute to the generation of, or may be required for, these premature ageing diseases. 
Taken together, these observations strengthen the notion that telomerase activity and 
telomere length maintenance play an important role in the manifestation of human 
diseases associated with accelerated telomere attrition. 
 
1.5 Oxidative DNA Damage in Telomere Attrition and Aging 
 Telomere attrition is frequently associated with aging and premature aging 
syndromes, and it has been proposed that oxidative stress plays a role in telomere attrition 
in aging (101). High oxygen levels and mitochondrial dysfunction-induced reactive 
oxygen species (ROS) accelerate telomere shortening and reduce the proliferative 
lifespan of human somatic cells in vitro, whereas these phenotypes are delayed when 
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cells are grown in low oxygen or in the presence of antioxidant (101). Interestingly, 
human cells with long telomeres show increased sensitivity to hydrogen peroxide, but not 
to etoposide and bleomycin, supporting the notion that telomeres are particularly 
vulnerable to oxidative damage (102). High oxygen levels also severely limit the 
replicative lifespan of primary mouse embryonic fibroblasts (MEFs) (103), however, it is 
not known if oxidative stress causes telomere-shortening and telomere capping defects in 
MEFs. Nevertheless, primary MEFs with critically short telomeres display a premature 
senescence-like arrest as well as reduced spontaneous immortalization (104). These 
results suggest that oxidative stress associates with telomere defects, which, in turn, play 
a role in cellular senescence in vitro.  
A number of reports demonstrate that oxidative DNA damage causes more single 
strand breaks (SSBs) in telomeric than in non-telomeric DNA, and it has been proposed 
that SSBs could be a major cause of telomere shortening (105). The telomeric G triplets 
are especially sensitive to cleavage by H2O2
 





in vitro (106-108). Oxidative stress by prolonged culture in 
the presence of 20% oxygen or H2O2
 
increases the frequency of SSBs in telomeres, 
especially in the G-strand (109,110). Several studies have shown that oxidation also 
induces oxidative base damage preferentially at telomeric DNA in vitro. For example, 
oxidative damage is several fold more efficient in inducing 8-oxo-7,8-dihydroguanine (8-
oxodG) in oligonucleotides containing telomeric repeats than non-telomeric repeats, even 
though the latter have similar G-content (106-108). Oxidized guanines occur at either the 
5’ or the middle G in GGG triplets (106-108). Thus, telomeric G triplets may act as sinks 
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for oxidative damage, and the presence of enough telomere repeats may serve as a buffer 
to protect the bulk genome from oxidative DNA damage. In vitro experiments show that 
the presence of 8-oxodG at single- or double- stranded telomeric nucleotides disrupts 
telomerase activity (111)
 
and inhibits binding of TRF1 and TRF2 (112), respectively. 8-
oxodG lesions at every telomeric repeat dramatically reduce binding of TRF1 and TRF2 
(112). However, it is not clear whether 8-oxodG or other oxidized bases accumulate and 
have similar effects at telomeres in vivo. Thus, thorough investigation on this matter is 
warranted since evidence indicates that these shelterin proteins regulate telomerase 
extension, telomere capping, and efficient telomere replication (3,4). 
 
1.6 Summary 
The mammalian telomeres provide protection at the ends of linear chromosomes 
which is an essential aspect in maintaining overall genome stability. A number of factors 
contribute to this protective role, mostly through concerted efforts between core members 
of the shelterin complex and its associated proteins, and telomerase. Failure to cap the 
chromosome ends have shown to have devastating effects, which include, but are not 
limited; to cell death, cell proliferation defects and increased incidence of malignancies. 
The importance of telomere integrity can be observed in a number of age-related human 
diseases and pre-mature ageing syndromes. These disorders have mutations in genes 
regulating telomere maintenance, accompanied by accelerated telomere shortening. 
Studies indicate that the maintenance of telomere length is tightly regulated and that it 
requires a highly specialized group of proteins for its maintenance. Telomerase, a 
ribonucleoprotein complex, replenishes replication dependent-telomere repeat loss and is 
 
- 24 - 
essential in telomere length maintenance. However, ALT mechanism can provide length 
maintenance through HR-dependent DNA repair if necessary. 
Although our current understanding of the telomere field has grown immensely, 
there are still many unanswered questions which need to be addressed. In particular, a 
clear picture of telomere maintenance and its relationship with DNA repair is warranted. 
This will help foster a better understanding of the functional significance of telomeres 
and could one-day lead to therapeutic solutions for a range of human disorders. 
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2.1 Introduction  
The structural integrity of DNA is continuously challenged by a daily assault from 
a variety of DNA damaging agents (both endogenous and exogenous). Exogenous DNA 
damages come from various environmental sources such as ultraviolet radiation (UV), 
ionizing radiation (IR) and chemicals, while endogenous DNA damages mostly come 
from reactive oxygen species (ROS) generated from cellular metabolism. It is estimated 
that roughly thousands of single strand breaks (SSB) and spontaneous base losses occur 
daily in the nuclear genome of every cell; inclusion of other types of spontaneous DNA 
damages generate a total number of DNA damages of approximately 100,000 lesions per 
day. When these staggering amounts of damages are not properly repaired, it can lead to 
genome instability, cell proliferation defects, and cell death. These effects have been 
known to cause embryonic lethality, accelerated ageing, cancer, and a number of 
premature ageing syndromes at the organism level (113).  
To counteract the constant threats from DNA damage, organisms have developed 
a number of DNA repair pathways to ensure that the integrity of genome remains intact. 
These pathways include, but are not limited to the base excision repair (BER) pathway, 
the mismatch repair pathway, the nucleotide excision repair pathway, the homologous 
recombination pathway, and the non-homologous end joining pathway; each repair 
pathway specializing in specific types of DNA damage (Fig. 2.1). Although most of these 
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Figure 2.1 – The DNA repair pathways 
The diagram demonstrates the consequence of DNA damage from a variety of damaging agents and 
subsequent DNA repair via multiple pathways. 
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repair pathways utilize a number of repair proteins, in some cases, loss of function of key 
repair proteins can have serious consequences. On the other hand, loss or inactivation of 
some repair proteins do not impact their respective repair pathways since they lack 
functional significance at both the cellular and organism level (114). These findings 
suggest that not all DNA repair proteins are created equal. Thus, careful examination of 
their roles in their respective repair pathways will expand our understanding and may 
play a crucial part in the development of treatment and drugs for various human diseases. 
In this chapter, two repair proteins will be examined; in particular, 8-oxoguanine DNA 
glycosylase-1 (OGG1) and Fanconi Anemia Complementation Group C (FANCC), and 
their role will be discussed in their respective DNA repair pathways.  
 
2.2 OGG1 and the BER pathway  
The BER pathway is one of the simplest yet most highly conserved pathways 
among other predominant DNA repair pathways in mammalian system. It is the primary 
DNA repair pathway that repairs non-bulky damaged bases, abasic sites, and SSBs 
induced by methylation, ROS, and spontaneous hydrolysis (115). Although it is one of 
the simplest among other repair pathways, there are two modes of repair as illustrated in 
Figure 2.2 and described below.  
The initial step in BER is base removal by a DNA glycosylase. The enzyme first 
recognizes a specific damaged base then cleaves the glycosylic bond that links the base to 
the sugar phosphate backbone. This creates an abasic site, also known as the 
apurinic/apyrimidinic (AP) site. The removal of the AP site is crucial since these sites can 
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also occur through spontaneous depyrimidination and depurination and is highly 
mutagenic (116,117). The subsequent repair steps involve either short patch repair, in 
which only one damaged nucleotide is replaced, or long patch repair, in which up to 
thirteen adjacent nucleotides are replaced along with the damaged one, both pathways 
involve the incision of the phosphodiester backbone by the abasic endonuclease (APE1). 
In the short patch pathway, mammalian polymerase beta’s (Pol β) 
deoxyribophosphodiestrase (dRPase) activity removes the 5’-dRP terminus left by APE1. 
On the other hand, either mammalian Pol γ or Pol ε extends from the 3’-OH group 
created by APE1 for up to thirteen nucleotides by displacing the strand containing the 5’-
dRP terminus in long patch repair. The resulting ‘flap’ structure in long patch repair is 
promptly removed by the structure-specific flap endonuclease (FEN1), producing a gap. 
Subsequently, the gap in both short and long patch repairs is filled in by Pol β, followed 
by either DNA ligase I or III, which seals the remaining DNA strand breaks. 
Alternatively, subsets of DNA glycosylases possess additional AP lyase activity. 
For example, OGG1 and endonuclease VIII (Nei)-like protein 1 (NEIL1) can both excise 
the damaged base and then additionally incise 3’ to the AP site, producing a SSB with 
either a 3’-α,β unsaturated aldehyde or a 3’-phosphate (118). The resulting 3’ terminus is 
cleaned by 3’ diestrase activity of APE1, followed by repair synthesis by Pol β, and nick 
sealing by DNA ligase I or III (Fig. 2.2). These DNA gylcosylases with additional 
functions are considered bifunctional while monofunctional glycosylases such as uracil 
DNA glycosylase (UNG) have only glycosylase activity. They require additional enzyme 
such as APE1 for the incision of subsequent AP sites (118). All DNA glycosylases can 
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Figure 2.2 – The Base Excision Repair (BER) pathway 
It divides into two pathways, short patch and long patch, and utilizes overlapping components with few 
exceptions. 
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cleave glycosylic bonds, however, each enzyme has its own preference to specific base 
substrates and reaction mechanisms. Several DNA glycosylases with distinct but 
overlapping substrate specificities have been characterized (Table 2.1). For example, 
DNA glycosylases such as OGG1 and NTH1, which belong to the E. coli endonuclease 
III (Nth) family, excise oxidized base lesions in double strand DNA. NEIL1 and NEIL2 
DNA glycosylases, which belong to E. coli Fpg/Nei family, can also excise base lesions 
in double strand DNA, but their preferred DNA substrates are single strand DNA, bubble 
DNA, or forked DNA (119). The adenine-specific mismatch DNA glycosylase, MYH, 
removes the adenine opposite 8-oxodG (120,121).  
BER pathways have been well-characterized for their role in repairing oxidative 
lesions which are produced at high rates via both endogenous and exogenous DNA 
damaging agents. The endogenous DNA damage is mainly caused by ROS attacks and 
guanines are particularly susceptible to ROS oxidation since they have a low redox 
potential (122). Particularly, it is estimated that approximately 100–500 8-oxodG lesions 
are formed in a cell everyday (123). 8-oxodG is one of the most frequent and widely-
studied forms of DNA damage generated by ROS and is commonly used as a biomarker 
for oxidative stress level (124). 8-oxodG can be extremely harmful to cells because it is 
able to mimic thymine in the syn conformation by forming an 8-oxodG (syn) to adenine 
(anti) base pair. This structural modification is brought upon by addition of an oxo group 
on the 8th carbon (C8) and a hydrogen atom on the 7th nitrogen (N7) (Fig. 2.3). If not 
repaired, DNA polymerases can bypass 8-oxodG during DNA replication, and results in 
guanine-to-thymine transversion mutations as a consequence (122). To alleviate this high 
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Table 2.1 – DNA glycosylase substrate specificity 
 
Enzyme Type DNA substrate Preferred lesions* 
OGG1 Bifunctional dsDNA 8-OxoG, Fapy G; prefers 
lesion opposite C 
NTH1 Bifunctional dsDNA 5-OHU, 5-OHC, TG, Fapy 
G, Fapy A 
NEIL1 Bifunctional ssDNA, bubble, fork and dsDNA  5-OHU, 5-OHC, TG, Fapy 
G, Fapy A 
NEIL2 Bifunctional ssDNA, bubble, fork and dsDNA 5-OHU and 5-OHC 
MYH Monofunctional dsDNA A opposite 8-OxoG 
 
*Fapy, formamidinopyrimidine; 5-OHC, 5-hydroxycytosine, 5-OHU, 5-hydroxyuracil; TG, thymine glycol; 
the list does not cover all the DNA glycosylases or substrates, especially poor substrates. 
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Figure 2.3 – The base flipping of guanine  
(A) ROS attacks guanine by adding oxygen at carbon 8, which flips the base to create a Syn formation. (B) 
The Syn formation of oxidized guanine base pairs with cytosine (left) or adenine (right) after one round of 
DNA replication.
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mutagenic potential of 8-oxodG, both prokaryotes and eukaryotes have come to rely on a 
group of DNA glycosylases for repair. In particular, the MutM, MutT, and MutY 
enzymes in bacteria and MTH1, OGG1, and MYH enzymes in human are mainly 
responsible for repairing 8-oxoG lesions in the BER pathway (125). 
DNA glycosylase OGG1 is one of the most characterized enzymes in the BER 
pathway. In the mammalian system, it has been recognized to be the primary enzyme 
responsible for excising 8-oxodG lesions (125). The OGG1 protein was initially 
discovered in Saccharomyces cerevisiae and subsequent database search and cloning 
studies have lead to the identification of the human homolog. The sequence alignment 
between human and yeast OGG1 proteins revealed ~38% homology between the two. 
However, over ~60% homology was observed in segments including the highly 
conserved active site Helix-hairpin-Helix-Lysine/Glycine/Proline/Aspartic Acid motif 
and several unknown segments which suggest the structural importance in the enzyme’s 
function (126,127). Interestingly, an analysis of the human cDNA sequence revealed an 
existence of two forms of mRNA, coding for two varieties of OGG1, namely α−hOGG1 
and β−hOGG1. Comparison of these two proteins showed that they were identical in the 
first 316 amino acids and both have mitochondrial targeting signal (MTS) sequences at 
the amino terminal end (128). However, it was later shown that only α−hOGG1 has a 
nuclear localization signal (NLS) sequence at the carboxy-terminal ends while β−hOGG1 
does not. This finding was later confirmed by immunofluroresence studies, where 
α−hOGG1 was almost exclusively detected in the nucleus while β−hOGG1 was found in 
the inner membrane of mitochondria (128,129). These studies suggest that the NLS 
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sequence overcomes the MTS sequence in α−hOGG1 making it primarily active in the 
nucleus and that β−hOGG1 may be responsible for the 8-oxoG repair activities in 
mammalian mitochondria (130).  
The mRNA expression levels of human and mouse OGG1 have revealed that the 
expression is ubiquitous, but it varies from tissues to tissue. In mice, low expression of 
Ogg1 mRNA was detected while high expressions were observed in brain, testes, kidney, 
thymus, and intestine in humans (128,131,132). Sequence analysis revealed that the 
OGG1 gene contains a classic housekeeping gene promoter that is consistent with the 
ubiquitous nature of its expression pattern. Tissue to tissue variation could be explained 
by having a possible negative regulator region upstream of promoter site. Furthermore, 
expression levels and enzyme activities of OGG1 protein in human fibroblast culture 
were not dependent on cell cycle (133). 
The mammalian OGG1 have the typical Helix-hairpin-Helix- 
Lysine/Glycine/Proline/Aspartic Acid catalytic motif that is frequently found in DNA 
glycosylase with AP lyase activity (126). The substrate specificity for OGG1 was shown 
to be dependent on the base opposite to the 8-oxoG. For instance, the repair efficiency for 
removing the 8-oxoG which is base paired with cytosine was the highest while other 
bases were all significantly reduced (134). This is due to the conformational changes that 
allow the recognition of the 8-oxoG to cytosine base pair as the key in its catalytic 
mechanism. More specifically, hydrogen bonds made by Asparagine-149 and Aspartic 
acid-268 to cytosine and 8-oxoG, respectively, work like a locking mechanism. They 
both must be displaced to aid Lysine-249 to launch a nucleophilic attack at the carbon-1 
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glycosidic bond that connects 8-oxoG to the sugar backbone, promptly removing the 
lesion (Fig. 2.4). On the other hand, X-ray structure of protein/undamaged DNA 
complexes revealed that undamaged guanine was denied access into the active site 
pocket; thus allowing OGG1 to differentiate between 8-oxoG and undamaged bases 
(135,136). The significance of proper fit at the active site pocket was later strengthened 
when an opposing abasic site or SSBs towards the 3’ of the active site pocket was found 
to greatly reduce OGG1 incision activity (137-139). In addition, characterization of 
OGG1 shows that it can excise fork substrates and increase the incision efficiencies by 
positioning the 8-oxodG up to 3 nucleotides away from the opening (139). OGG1 prefers 
to work in processive mode where the enzyme will move from substrate to adjacent 
substrate without disengaging from the DNA (140). In addition, a sequence-dependent 
study shows that OGG1’s incision is affected by flanking sequences with preference to 
5’-(C/G)me-FapyC-3’ (141). 
If the 8-oxoG-cytosine base pair does not get repaired and replication takes place 
after bypassing the lesion, then DNA glycosylase MYH will recognize the resulting 8-
oxoG-adenine base pair and remove the adenine (142). This provides an opportunity for 
OGG1 to repair the 8-oxoG-cytosine base pair substrate after subsequent processing of 
the AP site, followed by one round of replication. These two repair proteins work 
cooperatively to ensure that the highly mutagenic 8-oxoG lesion is properly excised 
before mutations can harm the cells. 
 




Figure 2.4 – The catalytic pocket of OGG1 
(Top) Hydrogen bonds are made between Asparagine-149 and cytosine and Aspartic acid-268 and 8-oxoG 
to start the catalytic reaction. (Bottom) The Lysine-249 launches a nucleophilic attack at the carbon-1 
glycosidic bond that connects 8-oxoG to the sugar backbone to remove the lesion. Image courtesy of Bjørås 
and Barrett, 2002.
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The employment of the Ogg1 knockout mice model has been instrumental in 
examining the consequences of 8-oxoG in the context of a whole organism. Interestingly, 
Ogg1 knockout mice did not generate any obvious abnormal phenotypes. They were 
fertile, developed normally with comparable life span to wild type, and were mostly 
cancer free, except in one study with increased development of lung adenoma/carcinoma 
(143-145). The lack of predisposition to cancer in Ogg1 knockout mice is consistent with 
the slight increase, only two to three fold, in the mutation frequency of embryonic stem 
cells derived from Ogg1 knockout mice  (144). However, it was found that 8-oxoG 
accumulated at an increased level in a tissue and age-dependent manner. More 
specifically, the accumulation of 8-oxoG in liver was considerably higher and was the 
only organ to show significant increase. Also, this accumulation was only observed in 
older mice (143,146).  
The OGG1 gene is not associated with any cancer or human disorders, some 
studies suggest that deficiency in OGG1 could provide the initial step necessary in 
tipping the balance in the right direction for tumorigenesis. For instance, a number of 
tumors have guanine-to-thymine transversion mutations in p53 gene, a tumor suppressor 
gene most commonly mutated in various cancers, which is accompanied by a loss of 
locus containing the OGG1 gene (125). Although the Ogg1 single knockout mice were 
not highly predisposed to cancer, Myh and Ogg1 double knockout mice displayed 
increased incidence of lung and ovarian tumor formation. A subsequent study revealed 
that codon 12 of K-ras, an oncogene most commonly mutated in lung cancer, had a 
guanine-to-thymine transversion mutation (147). The double deficiency in Myh and Ogg1 
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had an additive effect by abolishing the main repair mechanism for oxidized guanines, 
thus making it highly susceptible to the hypermutator phenotype as described above. 
Together, these studies demonstrate the importance of OGG1 protein in providing one of 
the first lines of defense against oxidative DNA base damages as part of the BER 
pathway. 
 
2.3 Fanconi Anemia Complementation Group C (FANCC) protein and its role in 
DNA repair 
 
Fanconi Anemia (FA) is a rare genetic disorder transmitted in an autosomal 
recessive, or occasionally through X-linked means. The major complication associated 
with FA is progressive bone marrow (BM) failure and is one of the classical inherited 
BM failure syndromes (IBMFS). FA patients frequently exhibit increased predisposition 
to cancer and are often born with a variety of birth defects such as abnormal thumb or 
radii and short stature. Most FA patients do not make it beyond their young adulthood 
due to progressive BM failure or malignancy (148,149). Cells derived from FA patients 
are often characterized with chromosome abnormalities such as spontaneous 
chromosomal breakage and hypersensitivity to DNA interstrand cross-linking (ICL) 
agents such as cisplatin, psoralen/UV-A and mitomycin-C (MMC) (150). A measurement 
of chromosomal abnormality e.g. breaks after exposure to ICL agents is often used to 
diagnosis FA (151).  
FA is a genetically heterogeneous disorder and there are currently 13 known 
complementation FA types (FANCA, B, C, D1, D2, E, F, G, I, J, L, M and N) that 
participate in the FA pathway (Fig. 2.5) (152). Eight of these proteins (FANCA, B, C, E, 
 




Figure 2.5 – An illustration of the FA pathway 
There are 13 complementation types in the FA pathway. Eight of them form the FA core complex, which is 
required for monoubiquitination of FANCD2 and FANCI. FANCJ and FANCD1 works downstream of FA 
pathway.  
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F, G, L and M) form the FA core complex, and its assembly is mandatory for the 
monoubiquitination of FANCD2 and FANCI and their localization to chromatin. 
Abrogation in any of the FA core components disrupts the monoubiquitination of 
FANCD2 and FANCI, thus their ability to localize to chromatin (153). Some members of 
the FA core complex exist out in the cytoplasm and re-locate into the nucleus upon DNA 
damage, which is dependent on the nuclear localization signals of FANCA and FANCE. 
The mechanism that triggers the assembly of the FA core complex is still unclear. It is 
proposed that DNA damage caused by ICL agents such as MMC or ROS could activate 
the assembly. Alternatively, the FA core complex could be constitutively active during 
the S phase of the cell cycle since FA pathway is restricted and most active during that 
particular of the cell cycle (154). Once in the nucleus, the FA core complex associates 
with chromatin via FANCM and FAAP24 which are equipped with DNA-interacting 
domains. In addition, FANCM may play a vital part in moving the core complex along 
the DNA with its ATP-dependent DNA translocase activity (155). The localization of 
FANCD2 to DNA damage sites depends on the FANCL protein, which acts as an E3 
ubiquitin-ligase and monoubiquitinates FANCD2 and FANCI with its ring-finger-type 
ubiquitin-ligase (PHD) motif. Evidence of this comes from a FANCD2 mutant, which did 
not localize to chromatin since it could not be monoubiquitinated (156).  
The role of FANCD2 and FANCI after being recruited to a DNA damage site is 
still unclear. One line of evidence suggests that FANCD2 is involved in HR repair by 
recruiting BRCA2 to DNA damage sites (157). However, HR repair is only slightly 
affected in cells that are deficient in FA pathway, whereas HR repair is severely affected 
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in cells deficient in BRCA2 (158,159). Other studies suggest that FA pathway is involved 
in translesion synthesis during DNA repair by recruiting translesion polymerases to DNA 
damage site. For instance, translesion polymerase-deficient DT40 chicken cells showed 
hypersensitivity to ICL agents, and translesion polymerase REV1 and REV3 have been 
shown to participate to repair ICLs in the same pathway as FA proteins (160). This 
suggests that FANCD2 may have a similar function as a proliferating cell nuclear antigen 
protein during polymerase switching in response to DNA damage (160). 
Traditionally, it has been widely accepted that FA cells are mainly sensitive to 
ICL agents. However, accumulating evidences suggest that FA cells are also sensitive to 
other endogenous stresses as well (150). For instance, hypersensitivity to oxidative 
damage inducing agents was observed in FA-deficient cells (161,162). Other DNA 
damage-inducing agents such as ultraviolet or ionizing radiation also have been shown to 
activate the FA pathway (163). FA patients seem to acquire typical FA phenotypes such 
as progressive BM failure and predisposition to malignancy even in the absence of 
environmental ICL-causing sources (150). Furthermore, commonly used ICL-inducing 
agents such as MMC can also cause other types of DNA damage and have been shown to 
predominantly induce alkylation of bases over ICLs (164,165). These data suggest that 
FA proteins may not respond exclusively to ICLs and may have a broader role in 
responding to endogenous DNA damage. 
Accumulating evidence indicates that FA proteins may play a role in telomere 
maintenance, causing a number of studies linking disruption in telomere maintenance and 
IBMFS, including FA, to arise in recent years (7,166). For instance, an accelerated 
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telomere shortening has been observed in cultured primary FA fibroblasts when 
measured periodically during a long period of their lifespan (167). A similar result was 
obtained when telomere length was measured in FA patient’s peripheral blood leukocytes 
(168). Whether this accelerated telomere shortening is a direct consequence of FA 
deficiency is still under debate since the telomere shortening occurred at similar rate 
between FA and non-FA-cells (95). Furthermore, FA proteins do not seem to have a 
direct role in telomere maintenance, as seen in cells with normal and functional telomeres, 
since they do not co-localize to telomeres in primary fibroblast and telomerase-positive 
cells. However, co-localization and deletion studies using various ALT cell lines suggest 
that FA proteins may play a role in telomere maintenance in ALT systems (169,170). It is 
plausible that the FA pathway may act as a general DNA damage response since ALT 
cells have an active DNA damage response and dysfunctional telomeres (4). (A more 
detailed description of dysfunctional telomeres and ALT can be found in chapter 1). 
However, FA protein’s role in telomere length regulation and functions is still unclear. 
FANCC is one of commonly mutated FA genes in FA patients (~10%) and is 
conserved among vertebrates. Its encoded protein, FANCC is 63kD in size and interacts 
with FANCE and FANCF in the FA core complex. Interestingly, FANCC protein does 
not contain any discernible motifs or domains that could connect it to one of many known 
DNA repair pathways (152,171). Historically, FANCC was the very first FA gene to be 
discovered. This was achieved via somatic cell hybridization study, where sensitivity to 
MMC was measured to identify different complementation groups. Briefly, the cells 
derived from complementation group C patients were transfected with various cDNA 
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expression libraries. The hypersensitivity to MMC was corrected when the library 
containing FANCC cDNA was transfected, therefore leading to identification of the gene 
responsible for the rescue (Fig. 2.6) (172). 
Aside from participating in the FA pathway as the component of FA complex, 
FANCC protein has also been implicated in a HR-dependent DNA repair pathway. For 
instance, FANCC-deficient chicken DT40 cells had 2-fold increase in the rates of 
spontaneous sister-chromatid exchange (SCE) than its wild-type counterpart. The 
mechanism behind this event is partially dependent on Rad51 paralog XRCC3, an 
important player in HR, since Fancc/Xrcc3 double mutant had decreased SCE levels, 
similar to that of Xrcc3 single mutant (173). In addition, the SCE level in the Fancc/Blm 
double mutant was similar to Blm single mutant, which already had significantly 
increased SCE rates. This suggests that FANCC and BLM, a helicase implicated in 
bloom syndrome, may work together in the same pathway (173). Interestingly, the FA 
core complex, which includes FANCC, was purified as part of a multiprotein complex 
with BLM in HeLa cell extract. This complex, as revealed, is relatively large, about 
600kD in size, and is properly termed BRAFT (BLM, replication protein A (RPA), FA, 
and topoisomerase IIIα) (174). However, an exact mechanism of how BRAFT complex 
participates in HR-dependent repair is still unclear.  
Accumulating evidence suggests that FANCC may also play a role in oxidative 
DNA damage response. Mice deficient in both FANCC and SOD1, a Cu/Zn superoxide 
dismutase, showed that there was defective hematopoiesis due to oxidative induced stress 
(175). In addition, hypersensitivity to oxidative stress induced by H2O2 in FANCC-
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Figure 2.6 – The discovery of FA complementation group C 
The somatic hybridization technique was utilized to identify the underlying gene. Briefly, various cDNA 
libraries are transfected into cells derived from FA patients; followed by mitomycin C (MMC) treatment. 
The underlying gene in the cDNA library complements the mutated gene in cells derived from FA patients; 
thus, surviving the MMC treatment. 
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deficient murine embryonic fiboblasts and BM hematopoietic progenitor cells was also 
observed. In this study, chemicals with an anti-oxidant property were able to increase the 
survival rates of FANCC deficient cells under oxidative stress conditions (161). The 
same group also showed that serine–threonine kinase apoptosis signal-regulating kinase 1 
(ASK1), a major player in oxidant-induced apoptosis, was hyper-activated in FANCC-
deficient cells under H2O2-induced oxidative stress conditions. Together, these data 
suggest that the redox states of these mice were altered and contributed to defective cell 
proliferation and enhanced apoptosis.  
Since FANCC-deficient cells are hypersensitive to oxidative stress, it is plausible 
that FANCC protein plays a direct role in redox homeostasis. Several studies indicate that 
FANCC protein directly interacts with NADPH cytochrome P450 reductase and 
glutathione S-transferase P1-1, which are known to primarily function in redox 
homeostasis (176,177). Whether FANCC or these interactions have significant impact in 
cellular response to oxidative stress or repair is still unclear. Interestingly, several studies 
suggest that FA proteins may work in conjunction with the tumor suppressor protein p53 
to regulate the oxidative DNA damage response. Mice deficient in Fanca demonstrated 
that hypersensitivity to H2O2-induced oxidative stress was correlated with overactivation 
of p53 (178), and cultured cells derived from FA patients showed altered p53 function 
under oxidative stress condition (179,180).  
The mechanism behind the functional linkage between the FA proteins and 
oxidative stress induced p53 activation is still not clear, however it has been shown that 
p53 and FA protein functionally cooperate to regulate tumorigenesis in FA deficient cells. 
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The Fancc and p53 double knockout mice displayed accelerated tumor development in 
hematopoietic or solid malignancies than in single p53 knockout mice, while no tumors 
were detected in Fancc single knockout mice. More importantly, this accelerated growth 
was associated with the appearance of tumor types that are found in patients with FA but 
not in p53 single knockout mice (181). These data suggest that the increased malignancy 
observed in FA patients perhaps could be explained by the concerted effort between p53 
and FA proteins in response to endogenous oxidative stress. 
The FA is both a genetically and functionally complex disease. It has many 
complementation groups and all members of the FA pathway appear to be indispensible. 
One of its members, FANCC, is not only part of the FA core complex but surprisingly 
has functions outside of the FA pathway. Therefore, further studies to possibly find 
additional complementation groups as well as more in depth genetic and functional 
studies could provide a more detailed picture of the disease.  
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Chapter 3: FANCC Suppresses Short Telomere-initiated 
Telomere Sister Chromatid Exchange 
 
 
The following chapter has been published as: David B. Rhee, Yisong Wang, Melissa 
Mizesko, Fang Zhou, Laura Haneline and Yie Liu, “FANCC suppresses short telomere-
initiated telomere sister chromatid exchange”, Human Molecular Genetics. 2010 March 







Telomeres are specialized structures consisting of tandem repeats, TTAGGG in 
human and mouse, together with telomere associated proteins to form caps at the ends of 
linear chromosomes (2,182). Telomeres prevent the recognition of chromosome termini 
as broken DNA ends and are critical to maintaining genomic stability. Telomere 
dysfunction, resulting from loss of telomere repeats or loss of protection by telomere-
associated proteins, can trigger DNA damage responses, cell apoptosis, cell proliferation 
defects, or genome instability. Telomere dysfunction has also been linked to bone 
marrow failure syndromes and tumor formation (3,183). Telomerase is essential in 
telomere length maintenance by replenishing telomere loss due to incomplete DNA 
replication (2). In mice, deficiency in either telomerase core component, telomerase RNA 
(Terc) or telomerase reverse transcriptase (Tert), leads to progressive telomere shortening 
(85-87,184), which is accompanied by cell proliferation defects and apoptosis in highly 
proliferating organs including the bone marrow (89,185,186). Furthermore, Terc or Tert 
heterozygous mice bred for increasing generations also exhibit progressive telomere 
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shortening and loss of tissue renewal capacity (184,187,188). In humans, mutations in the 
telomerase components are associated with accelerated telomere shortening and the 
development of bone marrow failure syndromes, such as dyskeratosis congenita, acquired 
aplastic anemia, and idiopathic pulmonary fibrosis (7). Previous reports show that 
peripheral blood cells derived from FA patients have shorter telomeres compared to age-
matched healthy donors (168,189-192), but it is unclear if telomere attrition in 
hematopoietic cells from FA patients contributes to the pathogenesis of bone marrow 
failure in FA. 
Telomere shortening is considered a biological clock counting down cellular 
replicative senescence (57). Cells may overcome this barrier and become immortalized 
by maintaining telomere length through activation of telomerase and homologous 
recombination (HR)-mediated pathways (52,57). In human and murine telomerase 
deficient cells, short telomeres can initiate HR between telomere sister chromatids, or 
telomere sister chromatid exchange (T-SCE), by which telomere length is maintained 
(50,68,69,193,194). Furthermore, short telomeres are also capable of initiating telomere 
recombination in the presence of telomerase (195). Although it is not entirely clear what 
molecules regulate telomere recombination, a loss of function in the pathways controlling 
telomere length maintenance, telomere capping, or telomere chromatin can affect 
telomere recombination. For example, inactivation of Werner (Wrn) protein promotes T-
SCEs in spontaneously immortalized telomerase-null mouse embryonic fibroblasts (196). 
Alterations in telomere capping or epigenetic modifications due to disruption of murine 
telomere capping proteins (e.g. Pot1 or Trf2 in combination with Ku70) or histone 
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methyltransferases (e.g. Suv4-20h or Suv39h) can also contribute to elevation of T-SCEs 
(197-200).  
Fanconi anemia is an autosomal recessive disorder characterized by cancer 
susceptibility, bone marrow failure, and cellular sensitivity to DNA inter-strand 
crosslinking agents. To date, 13 FA proteins (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, 
N) have been identified. Increasing evidence demonstrates that FA proteins play an 
important role in genome integrity via DNA replication-dependent repair (152,171). 
Several FA proteins form the FA nuclear core complex, which is required for the 
monoubiquitination of FANCD2 and FANCI and the localization of FA proteins to 
chromatin, possibly at the sites of DNA repair. FANCD2 and FANCI function as signal 
transducers and DNA-processing molecules in a DNA damage response network 
consisting of ATR, BRCA1, and a RecQ helicase, BLM. Abrogation in any of FA core 
components disrupts the monoubiquitination of FANCD2 and FANCI. FA proteins may 
respond to endogenous DNA damage, such as DNA inter-strand crosslinks or oxidative 
DNA damage (150). Whether the FA pathway can respond to dysfunctional telomeres is 
yet to be determined.  
FANCC is one of the most commonly mutated genes in FA patients and is 
conserved among vertebrates (201). Its encoded protein, FANCC is 63kDa in size with 
no discernable motifs or domains (152,171). FANCC is a member of the FA core 
complex where it interacts with FANCE and FANCF, and it also associates with the 
Bloom syndrome protein complex in a supercomplex called BRAFT (152,171,174). In 
addition to participating in monoubiquitination of FANCD2 and FANCI as part of the 
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core complex, FANCC is also involved in HR pathways (158,173,202). These 
observations, together with prior reports showing telomere shortening in FA patients, led 
us to investigate if FANCC regulates telomere length and telomere recombination in vivo. 
In this study, we employed Fancc deficient mouse models in the strain background with 
long (C57BL/6 strain) or short telomeres (telomerase reverse transcriptase mutant strain 
after successive breedings) and wild type recipient mice that had undergone serial 
transplantations with Fancc-/- bone marrow cells. Using these genetically modified 
murine models, we demonstrate that Fancc plays a role in stress-induced telomere 




Fancc deficiency does not compromise telomeres in a mouse strain with intrinsically 
long telomeres  
FA patients were reported to harbor short telomeres (168,189-192). To investigate 
if FANCC plays a direct role in telomere length maintenance in vivo, we examined 
telomere length of wild type and Fancc-/- mice in the C57BL/6 genetic background, 
known to have several-fold longer telomeres than humans (203). Hematopoietic cells 
were isolated from 2-4 month old mice. The mean and median telomere signal intensity 
as well as the distribution of individual telomere signal intensities were similar between 
wild-type and Fancc-/- mouse bone marrow cells by Q-FISH analysis (Figure 3.1). In 
addition, the average telomere signal intensity was comparable between wild type and 
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Figure 3.1 – Telomere lengths are comparable between wild type and Fancc
-/- 
bone marrow cells 
derived from C57BL/6 mice.  
Q-FISH analysis of bone marrow cells derived from wild type and Fancc-/- mice (n=6). (A) Representative 
metaphase spreads of wild type (Bi) and Fancc-/- (Bii) bone marrow cells showing DAPI staining (blue) 
and telomere fluorescence signals (red). There was no significant difference in the mean telomere signal 
intensities and distribution of telomere signal intensities between two genotypes in overlapping histogram 
(Biii) and box-plot (C).
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Fancc
-/- bone marrow, spleen, and thymus cells via Flow-FISH measurements (Figure 
3.2). No significant differences in telomerase activity and the expression of the 
telomerase core components, Tert and Terc were observed between wild type and Fancc-
/- mouse bone marrow cells (Figure 3.3).  
Accumulating evidence suggest that telomere integrity depends not only on 
telomere length, but also on the proper capping of chromosome ends by telomere 
associated proteins and telomere special structures (3,183,204). Therefore, telomeres with 
normal length do not necessarily reflect that they are functionally capped. To explore if 
FANCC plays a direct role in telomeric end-capping in vivo, we examined Fancc-/- bone 
marrow cells for evidence of telomeric end-capping defects, i.e. chromosome end-to-end 
fusion and telomere signal free end (SFE). Fancc-/- bone marrow cells did not exhibit 
chromosome end-to-end fusions and SFEs (Figure 3.1 and Table 3.1). Furthermore, 
Fancc
-/- bone marrow cells did not display spontaneous chromosomal abnormalities, e.g. 
chromosome breakages and fragments (Table 3.1). Together, these results suggest that 
FANCC does not play a direct role in regulating telomere length, telomerase activity, and 
telomeric end-capping, when telomeres are long and functional.  
 
Inactivation of Fancc accelerates telomere attrition in serially transplanted bone 
marrow cells  
In both humans and mice, telomere dysfunction leads to cell proliferation defects 
and apoptosis in highly proliferating organs, especially in the bone marrow 
(7,89,185,186). Fancc-/- mice do not have obvious bone marrow abnormalities (205). 
 




Figure 3.2 – Average telomere lengths in wild type and Fancc
-/-
 hematopoietic cells derived from 
C57BL/6 mice.  
Flow-FISH analysis of average telomere signal intensity of bone marrow cells, splenocytes, and 
thymocytes derived from wild type and Fancc-/- mice. Error bars represent the standard error from different 
mice of each genotype (n=5).
 




Figure 3.3 – Telomerase activity and Tert and Terc RNA level in wild type and Fancc
-/-
 mouse bone 
marrow cells derived from C57BL/6 mice.  
qT-PCR analysis indicates a comparable telomerase activity (A), and Tert and Terc RNA level (B) in wild 
type and Fancc-/- mouse bone marrow cells (n=6). Error bars represent the standard error obtained from 
different mice of each genotype. P-values are not significant between wild type and Fancc-/- mouse bone 
marrow cells.
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Table 3.1 – Frequencies of chromosomal and telomeric abnormalities in bone marrow cells derived 
from wild type and Fancc
-/- 










Cell Types Aneuploidya Chr. fragments & breaksb SFEsb 
Wild type 7.9% ± 1.8%  0% 0% 
Fancc
-/- 16% ± 4.3% 0% 0% 
p-value 0.1842 NA NA 




21.6% ± 1.7%   
 
0.42% ± 0.21%  
 
4.33% ± 1.22% 
G2 Tert-/-Fancc-/- 7.2% ± 4.9%   0.63% ± 0.29%  0.73% ± 0.32%  
p-value 0.07328 0.3948 0.0024 
 
a % of abnormal cells.  b % of abnormal events per chromosome. SFE: telomere signal free end. The data 
were obtained from wild type and Fancc-/- mice (n=6) as well as G2 Tert-/-Fancc+/+ and G2 Tert-/-Fancc-/-
mice (n=6), and more than 50 mouse bone marrow cells from each mouse were scored. P-values were 
calculated by comparing wild type with Fancc-/- , or G2 Tert +/- Fancc+/+ with Tert +/- Fancc-/- bone marrow 
cells.
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Thus, it is not surprising that the mutant mice do not have any detectable telomere defects. 
On the other hand, Fancc-/- bone marrow cells display decreased hematopoietic stem cell 
repopulating ability after primary and secondary transplantations (206,207). It is unclear 
if telomere length is altered in Fancc-/- hematopoietic cells during serial bone marrow 
transplantation and consequently contributes to the decreased repopulating ability of 
these cells. Utilizing Q-FISH analysis, we examined telomere length of wild type and 
Fancc
-/- bone marrow cells, which had previously undergone serial transplantation in 
lethally-irradiated secondary recipient mice. Wild type bone marrow cells from 
secondary transplant recipients had a decrease in mean and median telomere signal 
intensity compared to wild type bone marrow cells from untransplanted mice (mean 
telomere signal intensity was 34,780 and 82,930, after and before transplantation, 
respectively) (Figures 3.1 and 3.4). Interestingly, Fancc-/- bone marrow cells from 
secondary transplant recipients had an additional reduction in telomere signal intensity 
compared to transplanted wild type cells (Figure 3.4). The appearance of chromosome 
ends with greatly reduced or no detectable telomere signals was increased in Fancc-/- 
hematopoietic cells from secondary transplant recipients (Table 3.2). To investigate 
whether altered telomerase activity during serial transplantation accelerated telomere 
attrition in Fancc-/- bone marrow cells, we next examined telomerase activity. Deletion of 
Fancc had no effect on telomerase activity in serially transplanted bone marrow cells 
(Figure 3.5). Furthermore, spontaneous chromosomal abnormalities, including 
aneuploidy and chromosome breakages, were not significantly different between wild 
type and Fancc-/- hematopoietic cells (Table 3.2). Collectively, these data indicate that 
 




Figure 3.4 – Accelerated telomere attrition is observed in Fancc
-/-
 bone marrow cells after two serial bone marrow transplantations.  
Q-FISH analysis of wild type and Fancc-/- bone marrow cells after two serial bone marrow transplantation (n=4). (A) Representative metaphase spreads of wild 
type and Fancc-/- bone marrow cells showing DAPI staining (upper panel: blue) and telomere fluorescence signals (upper panel: red; lower panel: black). There 
was a decrease in telomere signal intensities in Fancc-/- cells (Bii) in comparison to wild type cells (Bi), shown here as shift of the dynamic range in overlapping 
histogram (Biii) and box-plot (C). 
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 bone marrow cells 
after two series of transplantations 
 
Cell types Aneuploidy a Fragments & breaks/chromosomes
b SFEsb 
Wild type 17% ± 6% 0.77% ± 0.32% 2.7% ± 1% 
Fancc
-/-  20.7% ± 4% 0.48% ± 0.27% 4.2% ± 0.8% 
p-value 0.7034 0.3619 0.03123 
 
a  % of abnormal cells. b % of abnormal events per chromosome. The data were obtained from wild type and 
Fancc
-/- mice (n=4), and more than 50 mouse bone marrow cells from each mouse were scored.
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Figure 3.5 – Telomerase activity in wild type and Fancc
-/-
 bone marrow cells after two serial bone 
marrow transplantations.  
qT-PCR analysis indicates a comparable telomerase activity in serially transplanted wild type and Fancc-/- 
mouse bone marrow cells (n=4). Error bars represent the standard error from different mice of each 
genotype.
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Fancc deficiency accelerates telomere attrition during the hematologic stress of serial 
bone marrow transplantation. 
 
Fancc deficiency promotes short telomere-initiated telomere sister chromatid 
exchange in late generation Tert mutant mice  
Although these data suggest that FANCC does not directly control long telomeres, 
it is unclear if FANCC regulates short telomeres. A body of evidence suggests that short 
telomeres can initiate recombinogenic events, including T-SCEs (50,68,69,193-195), 
even in the presence of telomerase (195). However, the molecular mechanism of short 
telomere-initiated telomere recombination is not well known. Given that FANCC is 
involved in HR pathways, we questioned whether FANCC may be involved in HR to 
resolve endogenous DNA damage, such as critically shortened telomeres. To test this 
hypothesis, we introduced Fancc+/- into Tert+/- mice (Figure 3.6). After successive 
breeding (Figure 3.6), bone marrow cells from Fancc+/+ and Fancc-/- (HG5 in Tert+/- 
background and G2 in Tert-/- background) exhibited decrease in overall telomere length 
and increases in the appearance of chromosome ends with greatly reduced, or non-
existent, telomere signals as detected by telomere restriction fragment and Q-FISH 
analysis (Figures 3.7 and 3.8, Table 3.1). These mutant mice with short telomeres 
allowed us to investigate the impact of Fancc deficiency on short telomere-initiated T-
SCEs in the presence or absence of telomerase. 




-/- bone marrow cells via CO-FISH analysis. In HG1 mice with long 
 
- 61 - 
 
 
Figure 3.6 – A schematic representation of mouse breeding strategy for different generation Tert 
mutant mice. 
 




Figure 3.7 – A significant reduction in overall telomere length was evident in HG5 mutant mice.  
(A) Telomere restriction fragment analysis of mouse bone marrow cells derived from HG1 and HG5 
Fancc+/+ and Fancc-/- mice. Genomic DNA was resolved by pulsed-field gel electrophoresis and 
hybridized with a radioactively labeled (AATCCC)4 probe. A significant decrease in telomere length was 
detected in HG5 mice in comparison to HG1 mice. (B) Q-FISH analysis of bone marrow cells derived from 
HG5 Tert+/- Fancc+/+ and Tert+/- Fancc-/-.
 












 mutant mice.  
Q-FISH analysis of bone marrow cells derived from G2 Tert-/- Fancc+/+ and Tert-/- Fancc-/- mice (n=6). Representative metaphase spreads of G2 Tert-/- Fancc+/+ 
and Tert-/- Fancc-/- mouse bone marrow cells showing DAPI staining (upper panel: blue) and telomere fluorescence signals (upper panel: red; lower panel: black). 
SFEs are detectable in G2 Tert-/- Fancc+/+ and Tert-/- Fancc-/- mice (see arrows).
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-/- mice (Figure 3.9). In HG5 mice with short telomeres (Figure 3.7), higher 
frequencies of T-SCEs were observed in Tert+/- Fancc-/-, compared to Tert+/- Fancc+/+ 




+/+) (Figure 3.9). T-SCEs further increased in G2 Tert-/- Fancc+/+ and Tert-/- 
Fancc
-/- bone marrow cells harboring critically short telomeres (see SFEs in Figure 3.8 
and Table 3.1), and the latter displayed more T-SCE events (average 24% T-
SCEs/chromosome in Tert-/- Fancc-/- and 13% T-SCEs/chromosome in Tert-/- Fancc+/+) 
(Figure 3.9). Thus, deletion of Fancc leads to elevated T-SCEs in late generation 
telomerase mutant mice with short telomeres. These observations suggest that short 
telomeres in late generation telomerase mutant mice become prone to T-SCEs and that 
inactivation of Fancc promotes T-SCEs.  
Inactivation of FANCC in chicken DT40 cells results in elevated genome SCEs 
(173). We hypothesized that inactivation of Fancc in mice would cause spontaneous 
genome SCEs that in turn contribute to T-SCE events. We examined the frequencies of 
genome SCEs in HG5 Tert-/- Fancc+/+ and Tert-/- Fancc-/- mouse bone marrow cells, and 
our data showed that the frequencies of genome SCEs in these mice were comparable 




-/-) (Figure 3.10). Thus, deletion of Fancc does not affect the rate of 
spontaneous genome SCEs in primary hematopoietic cells derived from late generation 
Tert
 mutant mice. 
 
 




Figure 3.9 – Fancc deletion increases the frequencies of telomere sister chromatid exchange in late generation Tert mutant mice.  
CO-FISH analysis of mouse bone marrow cells with indicated genotypes. (A) A schematic representation of CO-FISH procedure. In brief, newly synthesized 
strands are removed, leaving parental strands to be detected by fluorescent-labeled telomeric C-rich or G-rich probes. A chromosome with more than two 
telomere signals is considered to be positive for T-SCE. (B) Representative metaphase spreads of G2 Tert-/- Fancc+/+ and Tert-/- Fancc-/- mouse bone marrow cells 
showing DAPI staining (blue), leading strand telomere fluorescence signals (red) and lagging strand telomere fluorescence signals (green). Arrows indicate T-
SCEs. (C) The frequencies of T-SCEs in HG1, HG5, and G2 Fancc+/+ and Fancc-/- mice. Error bars represent standard errors from different mice of each 
genotype (n=3). 
 













 mouse bone marrow cells.  
(A) Representative metaphase spreads of bone marrow cells with indicated genotypes, showing genome 
SCE events. (B) (i) The incidences of genome SCEs are comparable between Tert-/- Fancc+/+ and Tert-/- 
Fancc
-/- bone marrow cells (n=4). Arrows indicate genome SCE events. (ii) The frequencies are derived 
from the number of SCE events divided by total number of chromosomes (%).
 
- 67 - 
3.3 Discussion 
In this study, we examined the role of FANCC in telomere length regulation and 
telomere recombination in vivo. Although deletion of Fancc did not directly affect 
telomere length or end-capping in a strain with long telomeres, it led to an increase in the 
incidence of T-SCEs in late generation telomerase mutant mice with short telomeres. 
These genetic data support the notion that FANCC does not directly regulate long 
telomeres, but does regulate short telomere-initiated telomere recombination. Thus, 
ablation of FANCC function may promote telomere recombination. To our knowledge, 
this is the first study to demonstrate a molecular event that regulates short telomere 
initiated-telomere recombination in non-transformed murine tissues. 
Fancc
-/- mice did not show telomere attrition or telomere defects in the C57BL/6 
genetic background that has exceedingly longer telomeres than humans. A similar 
observation was reported in a mouse model deficient in Fancg (95). Interestingly, in an 
experimental system that dramatically increases the hematopoietic stem and progenitor 
cell turnover (i.e. serial bone marrow transplantation); Fancc-/- bone marrow cells showed 
elevated telomere shortening compared to wild type bone marrow cells, even though 
telomerase activity was comparable in these cell types. Since Fancc-/- hematopoietic stem 
and progenitor cells exhibit increased cycling compared to wild type cells (208,209), it is 
possible that higher turnover of Fancc-/- bone marrow cells may accelerate telomere 
shortening, which may, in turn, contribute to decreased Fancc-/- hematopoietic stem cell 
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Late generation Tert-/- mice displayed short telomeres and increased T-SCE events. 
When Fancc was deleted, the incidence of T-SCEs was exacerbated. These observations 
suggest that inactivation of FANCC promotes short telomere-initiated T-SCEs. It is 
possible that Fancc inhibits short telomere-initiated telomere recombination in primary 
murine hematopoietic cells, but inactivation of Fancc leads to loss of this suppressive 
mechanism. The exact mechanism of how FANCC suppresses telomere recombination is 
unclear. FANCC does not directly bind to DNA (176), and it may thus regulate proteins 
or pathways that are involved in telomere recombination. As a component of the FA core 
complex, FANCC regulates the monoubiquitination of FANCD2. A previous report 
demonstrates that the modified FANCD2 localizes to telomeres in an immortalized cell 
line that maintains telomeres through HR based mechanisms; however, depletion of 
FANCD2 causes increased short telomeres and decreased T-SCEs in this line (170). 
These telomere phenotypes are in contrast to the observations in HG5 Tert+/- Fancc-/- and 
G2 Tert-/- Fancc-/- mice. A possible explanation for these apparent inconsistencies could 
be that FA proteins may not only serve as checkpoint proteins that prevent primary cells 
from the engagement of illegitimate telomere recombination, but also regulate the 
maintenance of telomere recombination to keep the shortest telomeres intact in 
immortalized cells. Alternatively, these discrepant findings may be because the former 
study employed an immortalized cell line that had already escaped checkpoints for the 
illegitimate telomere recombination, while our studies utilized primary hematopoietic 
cells with intact checkpoints for illegitimate telomere recombination. FANCC also 
associates with the Bloom syndrome protein complex (174). It has been shown that the 
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frequencies of spontaneous SCEs in fancc and blm double mutant chicken DT40 cells are 
similar to those in blm single mutant (173). These studies suggest a functional linkage 
between FANCC and BLM in a common pathway to suppress sister chromatid exchange. 
Deletion of Fancc leads to reduced levels of Blm in mice (Suhasini AN and Brosh RM, 
personal communication). Decreased Blm levels may thus serve a role in promoting 
telomere recombination in Fancc and Tert double mutant mice. Although ablation of 
another member of RecQ helicase proteins, Wrn also results in elevated T-SCEs in late 
generation telomerase null mice (196), the Wrn and telomerase double null cells display 
elevated incidence of critically short telomeres (196). In contrast, Fancc deficiency 
reduces the incidence of critically short telomeres in late generation telomerase null mice 
(Table 3.1). These observations do not support the involvement of Wrn in Fancc-
regulated telomere recombination in mice. However, deletion of fancc in chicken DT40 
cells can lead to elevated spontaneous SCEs that depends upon a key HR protein, the 
RAD51 paralog, XRCC3 (173). In addition, ablation of murine telomere capping proteins 
(e.g. Pot1 or Trf2 in combination with Ku70) and histone methyltransferases (e.g. Suv4-
20h or Suv39h) can cause elevated T-SCEs (197-200). It is unknown if FANCC regulates 
XRCC3, telomere binding proteins, or histone methyltransferases in telomere 
recombination. 
FA patients without functional FA proteins are predisposed to bone marrow 
failure and malignancies (152,171). FANCC may therefore control cell viability and 
immortalization of primary cells, including bone marrow cells, by safeguarding genome 
stability. Telomere dysfunction triggers cell apoptosis and genomic instability 
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preferentially in highly proliferating organs, e.g. bone marrow. In rare events, cells may 
overcome this barrier and become immortalized by activating the pathway involved in 
maintaining telomere length (52). Increasing evidence suggests that short telomeres 
initiate telomere recombination likely due to a dysfunction in the highly regulated 
mechanisms controlling homologous recombination. We have shown that inactivation of 
FANCC facilitates short telomere-initiated telomere recombination. In addition, Fancc 
deficiency can accelerate telomere shortening during high hematopoietic cell turnover. It 
is possible that FANCC may function to control cell viability and immortalization of 
primary cells by influencing telomere attrition and telomere recombination. 
 
3.4 Materials and Methods  
Mice 
Fancc and Tert knockout mice (Fancc-/- and Tert-/-) in C57BL/6 genetic 
background were produced as described previously (87,184,205,206). Figure 3.6 
illustrated mouse breeding strategy. In brief, Tert and Fancc heterozygous mice (Tert+/- 
Fancc
+/-) were generated by interbreeding Tert+/- and Fancc+/- mice and were named as 
heterozygous generation 1 (HG1) mice. HG1 mice from separate mating events were 
mated to obtain HG2 mice, which were crossed again until generation 5 (HG5). Tert-/- 
Fancc
+/- mice were generated from HG5 Tert+/-Fancc+/- breeders and were named as 
generation 1 (G1) mice. G1 mice from separate mating events were mated to obtain G2. 
All animal experiments were carried out according to the “Guide for the Care and Use of 
Laboratory Animals” (National Academy Press, USA, 1996) and were approved by the 
NIA IACUC. 
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Serial mouse bone marrow transplantation 
Bone marrow was flushed from tibias and femurs of experimental mice and low-
density mononuclear cells were prepared by density centrifugation (ficoll-hypaque 
density 1.119, Sigma, St. Louis, MO). Primary and secondary transplants were conducted 
as described previously with slight modification (206,207). Briefly, low-density 
mononuclear bone marrow cells (2x106 cells) were resuspended in 200 µl IMDM 
supplemented with 20% fetal bovine serum (FBS, Biowhittaker, Walkersville, MD). 
Cells were transplanted into congenic lethally-irradiated B6.SJL-PtrcaPep3b/BoyJ 
recipient mice obtained from the Stem Cell Transplant Mouse Core in the Indiana 
University Cancer Center. Bone marrow from primary recipients was harvested 12 
months after transplantation and prepared for secondary transplantation. Secondary 
transplants were conducted exactly the same as primary transplants. Four months after 
secondary transplantation, bone marrow was harvested for telomere studies. 
 
Telomere length measurements  
Flow-FISH: the average telomere fluorescence in splenocytes, thymocytes, and 
bone marrow cells was scored for each mouse and the data were pooled from the 
indicated number of mice in each genotype and measured according to previously 
published protocol with minor modifications (210). A telomere specific FITC conjugated 
(CCCTAA)3 PNA probe (0.3 µg/ml, Panagene) was used.  
 
- 72 - 
Q-FISH: Mice were injected with 100 µl of 0.5% colchicine intraperitoneally for 
approximately 30 minutes before being scarified. Bone marrow cells were then collected 
by flushing 1ml of PBS from femurs. Collected bone marrow cells were immediately 
incubated in 0.075M KCl for 15 minutes in 37oC, followed by fixation in ice-cold (3:1) 
methanol and glacial acetic acid. Metaphase spreads were then hybridized with a Cy3–
labeled PNA (CCCTAA)3 probe (0.3 µg/ml, Panagene) and counterstained with 4,6 
diamidino-2-phenylindole as previously described (211). Images were captured using 
Cytovision™ software (Applied Imaging Corp.) on a fluorescence microscope (Axio2; 
Carl Zeiss, Germany), followed by quantification of telomere fluorescence signals using 
the TFL-Telo software (a kind gift from P. Lansdorp, Vancouver, BC). For histograms 
and box-plots, data from different mice of each genotype were pooled and scored and R 
statistical package (http://www.braju.com/R/) along with R.utils package and Biobase 
package (http://www.bioconductor.org/) was used. The frequencies of telomeres within a 
given range of telomere signal intensities were plotted against the telomere signal 
intensity using arbitrary units. Metaphases from different mice of each genotype were 
scored for chromosomal and telomeric abnormalities (i.e. frequencies of cells with > or < 
40 chromosomes, frequencies of chromosomal fragmentations and breakages, and 
frequencies of chromosome ends with no detectable telomere signals) as previously 
described (193,212).  
Telomere restriction fragment analysis:  The analysis was carried out as described 
by Hemann et al. (213). Approximately 1 X 106 mouse bone marrow cells were 
embedded in agarose plugs. DNA was digested with DnpII (BioLabs) and 
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electrophoresed through 1% w/v pulsed field grade agarose (Bio-Rad) in 1 X Tris-
acetate-EDTA buffer. Electrophoresis was carried out in a CHEF DR-III pulsed-field 
apparatus (Bio-Rad) at 14°C with 3 volt/cm and a switch time of 10 sec for 48 h. The gel 
was denatured, dried, probed with P32-labeled (AATCCC)4 probe, and visualized by 
autoradiography. 
 
Measurement of telomere sister chromatid exchange (T-SCE) and genome sister 
chromatid exchange (SCE) 
Chromosome orientation FISH (CO-FISH) was used to measure the frequency of 
T-SCE (50). The measurement for genome SCEs was carried out as described previously 
(193). Briefly, bone marrow cells were flushed from femurs and tibias and cultured with 
Iscove's modified Dulbecco's medium (IBCO-BRL, Gaithersburg, MD) supplemented 
with 20% fetal calf serum (Hyclone, Logan, UT) in the presence of interleukin 6 (200 
U/mL) and stem cell factor (100 ng/mL; Peprotech Rocky Hill, NJ) (206). Bone marrow 
cells were subcultured in medium containing a 3:1 ratio of BrdU/BrdC (Sigma) at a final 
concentration of 1 x 10-5 M and collected around 12 or 24 hours for detecting T-SCE or 
SCE, respectively. Colcemid (0.1 µg/ml) was added 2 hours before harvest. Metaphase 
spreads were then stained with Hoechst 33258, exposed to UV light, and digested with 
exonuclease III to remove newly synthesized DNA strands. Hybridization and wash 
conditions were identical to those described for telomere FISH (211). A chromosome 
with more than two telomeric DNA signals by FITC-labeled (CCCTAA)3 or Cy-3-
labeled (TTAGGG)3 PNA probes (0.3 µg/ml, Panagene) was scored as T-SCE positive. 
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A SCE was scored each time a color switch between dark or light sister chromatids 
occurred. The frequencies of T-SCEs and SCEs were obtained from different mice of 
each genotype. 
 
Analysis of telomerase activity and Tert and Terc level 
Telomerase activity was measured by using Biomax Telomerase detection kit 
(Biomax Inc., MD, USA) according to the manufacturer’s recommendations. Briefly, 
freshly isolated bone marrow cells were lysed, and the cell extracts were then added to a 
pre-mix for quantitative telomerase activity in a real-time PCR reaction. For detecting 
Tert and Terc level, total RNA was extracted from mouse bone marrow using RNeasy kit 
(Qiagene) and then reverse-transcribed with random hexamers by the SuperScript III 
first-strand synthesis system for RT-PCR (Invitrogen Life Technologies). The PCR 
reaction included cDNA reaction, 2x Sybr master mix (Biorad), and a set of primers for 
mouse Tert, Terc, or Beta-Actin (Table 3.3). The levels of Tert and Terc were normalized 
to that of Beta-Actin. MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad, 
CA, USA) was used to conduct the reaction where each sample was done in triplicates 
and performed according to the manufacturer’s instructions. Tert deficient mouse bone 
marrow cell extracts or cDNA were used as control. Relative telomerase activity was 
expressed as log of CT value. Relative Tert and Terc RNA levels were normalized to 
Beta-Actin and expressed using the comparative CT method according to the 
manufacturer’s instructions. 
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Table 3.3 – Summary of primer sequences for qT-PCR analysis 
 
Primer Sequence 
Tert Forward 5’-TGGTGGAGGTTGTTGCCAA-3’ 
Tert Reverse  5’-CCACTGCATACTGGCGGATAC-3’ 
Terc Forward 5’-GTGGTGGCCATTTTTTGTCTAAC-3’ 
Terc Forward 5’-TGCTCTAGAATGAACGGTGGAA-3’ 
Beta-Actin Forward GACCTCTATGCCAACACAGTGCTG 
Beta-Actin Reverse CACCGATCCACACAGAGTACTTGC 
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Chapter 4: Characterization of Oxidative Guanine Damage 
and Repair in Mammalian Telomeres 
 
 
The following chapter has been published as: Zhilong Wang, David B. Rhee, Jian Lu, 
Christina Bohr, Birija S. Patro, Nadja C. de Souza-Pinto, and Yie Liu, “Characterization 
of oxidative guanine damage and repair in mammalian telomeres”, PLoS Genetics. 2010 
May 13; 6(5): e1000951. 
 






Telomeres are chromosome end nucleoprotein structures that are composed of 
telomere associated proteins and TTAGGG repeats in mammals (2). Telomeres cap 
chromosome ends and prevent them from being recognized as broken DNA. 
Dysfunctional telomeres, emanating from loss of telomere repeats and/or loss of 
protection by telomere-associated proteins, are recognized by many DNA damage 
response proteins, including γH2AX, 53BP1, and ATM that form telomere dysfunction-
induced foci (TIF) and induce cellular senescence or apoptosis (3,183). 
Telomere length homoeostasis is maintained through interplay among telomerase 
extension, telomere recombination, telomere replication, and telomere capping (2). 
Telomerase, a ribonucleoprotein complex, replenishes replication dependent-telomere 
repeat loss and is essential in telomere length maintenance (2). Telomere associated 
proteins also play a key role in telomere length regulation and capping. Mammalian 
telomeres are coated by a telomere protein complex, referred as shelterin. Shelterin 
includes telomere binding proteins TRF1, TRF2, and POT1 (3) that negatively control 
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telomere length in cis by limiting the access of telomerase to the ends of individual 
telomeres (36,53,214,215). Reduced telomere-bound TRF1 promotes telomere 
lengthening in human cells (214,215), but telomeres that are severely or completely 
stripped off the protective telomere protein complex result in telomere uncapping and 
evoke ATM or ATR dependent DNA damage response, nucleolytic degradation and 
undesirable recombination (28,29,31,197,198,216-218). Efficient telomere replication 
also requires the telomere associated proteins, e.g. TRF1 and WRN (219-222).  
Oxidative stress has been proposed to be a major cause of telomere shortening in 
cultured cells (101). For instance, normoxia, hyperoxia (40% oxygen), and mitochondrial 
dysfunction-induced reactive oxygen species (ROS) accelerate telomere shortening and 
severely reduce proliferative lifespan of human somatic cells in vitro; while these 
phenotypes are delayed when cells are grown in hypoxia or in the presence of 
antioxidants (101). Interestingly, human cells with long telomeres show increased 
sensitivity to hydrogen peroxide, but not to etoposide and bleomycin, supporting the 
notion that telomeres are particularly vulnerable to oxidative damage (102). These studies 
suggest that oxidative stress causes telomere shortening or damage; however it is unclear 
which types of oxidative DNA damage arise in telomeres and how they compromise 
telomere length and integrity. Previous studies have demonstrated that oxidative stress 
causes single strand breaks (SSBs) in telomeric DNA (105). Thus, telomere shortening 
could arise from SSBs. Oxidative stress has also been shown to induce oxidative base 
damage in telomeric oligonucleotides in vitro (106,108,223), and 8-oxoG at double-
stranded telomeric nucleotides attenuates binding by TRF1 and TRF2 (112). It is unclear 
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if oxidative base damage has any impact on telomere length and integrity in mammalian 
cells. 
Oxidative DNA damage, resulting from ROS, increases with age and can 
accumulate as a variety of oxidative modifications in purines and pyrimidines (115,224). 
Oxidized bases may lead to mutagenesis, block DNA replication, or alter the affinity of 
DNA binding proteins, which can, in turn, attenuate cell viability or promote 
tumorigenesis (119,225,226). BER is the primary DNA repair pathway for the repair of 
non-bulky damaged bases, and the initial step in BER is base removal by a DNA 
glycosylase. Several DNA glycosylases with distinct, but overlapping substrate 
specificities have been characterized, and OGG1 primarily excises 8-oxoG and FapyG 
paired with cytosine in duplex DNA (119,226). OGG1 is well conserved from bacterial to 
mammals, implying its significant functional importance in maintaining genome integrity 
(115,224). If 8-oxoG is unrepaired, it becomes highly mutagenic, because it can pair with 
adenine and lead to GC to TA transversions after two rounds of replication (227-229). 
The removal of adenine opposite 8-oxoG is via the adenine-specific mismatch DNA 
glycosylase, MYH (230). Mice lacking these repair genes exhibit an increased 
spontaneous mutation rate and a marked increase in tumor predisposition 
(144,147,230,231). In addition, Ogg1 and Myh deficient murine cells are sensitive to 
oxidative stress (232-234). These studies are consistent with the idea that oxidative base 
lesions contribute to genome instability, neoplastic transformation, and cell death. 
Ogg1 deficiency causes an increase in 8-oxoG and FapyG lesions in the mouse 
genome (144,225,235). This genetic model therefore allows us to study whether these 
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unique oxidative guanine lesions can affect telomere integrity. Here, we present evidence 
that deletion of the mouse Ogg1 gene attenuates telomere integrity via multiple ways. 
Thus, interfering with telomere integrity may be one of the mechanism(s) by which 
oxidative base damage leads to genome instability. 
 
4.2 Materials and Methods 
Mice and primary mouse cells  
The generation of Ogg1 null mice was described elsewhere (144). Ogg1-/- mice 
were further backcrossed into C57BL/6 background. Wild type and Ogg1-/- mice were 
derived from heterozygous (Ogg1+/-) breeders. Primary MEFs were isolated from 13.5 
day embryos of Ogg1+/- female bred with Ogg1+/- male and cultured in Dulbecco's 
Modified Eagle Medium containing 10% fetal bovine serum. Splenocytes were prepared 
from mouse spleens, cultured in RPMI 1640 with 10% FBS and 0.1% 2-mercaptoethanol, 
and stimulated with 50 µg/ml Escherichia coli LPS serotype O111:B4 (Sigma-Aldrich) 
and 50 ng/ml mouse IL-4 (R&D Systems). Bone marrow cells were flushed from femurs 
and tibias and cultured with Iscove's modified Dulbecco's medium (IBCO-BRL) 
supplemented with 20% fetal calf serum (Hyclone) in the presence of interleukin 6 (200 
U/mL; Peprotech) and stem cell factor (100 ng/mL; Peprotech). To decrease or enhance 





MCO-18M) or 20% oxygen or in the presence of paraquat. All animal experiments were 
carried out according to the “Guide for the Care and Use of Laboratory Animals” 
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(National Academy Press, USA, 1996), and were approved by the Institutional Animal 
Care and Use Committee of National Institute on Aging. 
 
Telomere quantitative fluorescence in situ hybridization  
The telomere fluorescence in cell populations of spleen, bone marrow, and 
primary MEFs was measured by Flow cytometry and FISH (Flow-FISH) according to 
previously published protocol (210). A telomere specific FITC conjugated (CCCTAA)3 
PNA probe (0.3 µg/ml, Panagene) was used. 
Quantitative FISH (Q-FISH) was performed as previously described 
(194,211,212). Metaphase spreads were prepared from freshly isolated or subcultured 
mouse bone marrow cells, activated splenocytes, and primary MEFs. Briefly, mice were 
injected with 100 µl of 0.5% colchicine intraperitoneally for approximately 30 minutes 
before being sacrificed. Bone marrow cells were then collected by flushing 1ml of PBS 
through femurs and tibias. Cultured mouse cells were incubated with 0.1 µg/ml colcemid 
for 2-6 hr at 37oC to allow mitotic cells to accumulate. Metaphase spreads were obtained 
by incubating colchicine- or colcemid- treated mouse cells in 0.075 M KCl for 15 
minutes in 37oC, followed by fixing cells in ice-cold 3:1 methanol and glacial acetic acid 
and dropping the fixed cells onto slides. Metaphase spreads were hybridized with Cy3-
labeled (CCCTAA)3 (0.3 µg/ml, Panagene), washed, and then counterstained with 4,6 
diamidino-2-phenylindole (DAPI). For the detection of telomere signal intensity in G and 
C strands, metaphase spreads were initially hybridized with FITC-labeled (CCCTAA)3 
PNA probes (0.3 µg/ml, Panagene). The free-(CCCTAA)3 probe were washed off the 
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slides, and then hybridized with TAMRA-labeled (TTAGGG)3 (0.3 µg/ml, Panagene). 
Images were captured using Cytovision™ software (Applied Imaging) on a fluorescence 
microscope (Axio2; Carl Zeiss); followed by quantification of telomere fluorescence 
signals using the TFL-Telo software (a kind gift from Dr. Peter Lansdorp). For 
histograms and box-plots, data from different mice of each genotype were scored and R 
statistical package (http://www.r-project.org/) along with R.utils package and Biobase 
package (http://www.bioconductor.org/) were used. The frequencies of telomeres within 
a given range of telomere signal intensities were plotted against the telomere signal 
intensity using arbitrary units. Metaphases from different mice of each genotype were 
scored for chromosomal and telomeric abnormalities as previously described (194,212). 
 
Telomerase activity  
Telomerase activity was measured by Biomax Telomerase Detection Kit 
(Biomax) according to the manufacturer’s recommendations. Briefly, mouse cell extracts 
were added to a pre-mix for quantitative telomerase activity in a real-time PCR reaction. 
MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad) was used to perform the 
reactions, where each sample was done in triplicates and performed according to the 
manufacturer’s instructions. HeLa cell extracts were used as positive control. Tert 
knockout mouse cell extracts and RNase-treated HeLa cell extracts were used as negative 
controls. Relative telomerase activity was expressed as log of CT value. 
 
Measurement of telomere sister chromatid exchanges (T-SCEs) 
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CO-FISH was used to measure T-SCEs and telomere lagging or leading strand 
loss (50,219). Briefly, mice were injected with 3:1 ratio of BrdU/BrdC (Sigma) at a final 
concentration of 1 x 10-5 M intraperitoneally for approximately 20 hours, and 
subsequently with 100 µl of 0.5% colchicine for approximately 30 minutes before being 
sacrificed. Bone marrow cells were then collected by flushing 1ml of PBS through 
femurs and tibias. MEFs were cultured in medium containing a 3:1 ratio of BrdU/BrdC 
(Sigma) at a final concentration of 1 x 10-5 M for 24 hours, and colcemid (0.1 µg/ml) was 
added 4 hours before harvest. Metaphase spreads were prepared from mouse bone 
marrow cells or MEFs, stained with Hoechst 33258, exposed to UV light, and digested 
with exonuclease III to remove newly synthesized DNA strands. Hybridization and wash 
conditions were identical to those described for Q-FISH. FITC-labeled (CCCTAA)3 and 
TAMRA-labeled (TTAGGG)3 PNA probes were used for the detection of lagging and 
leading strand, respectively. A chromosome with more than two telomeric DNA signals 
by both FITC-labeled (CCCTAA)3 and TAMRA-labeled (TTAGGG)3 PNA probes was 
scored as T-SCE positive. A chromosome with loss of one or two telomeric DNA signals 
by either FITC-labeled (CCCTAA)3 or TAMRA-labeled (TTAGGG)3 PNA probes was 
scored for telomere lagging or leading strand loss.  
 
Indirect immunofluorescence and telomere FISH (TEL-FISH) 
TEL-FISH was performed as described previously (212) with minor 
modifications. Briefly, cells were fixed in 1:1 methanol:acetone (Sigma) at –20oC for 10 
minutes, permeabilized with 0.5% NP-40, and blocked in 1% Bovine serum albumin 
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(BSA) (IgG-free, Sigma). Cells were first immunostained with a rabbit anti-γH2AX 
antibody (16193, Upstate Biotechnology), a rabbit anti-53BP1 antibody (BN 100-304, 
Novus Biologicals), or a mouse anti-XRCC1 antibody (X0629, Sigma) overnight at 4oC 
followed by Alexa 488-labeled secondary antibody (1:500; Molecular Probes) for one 
hour at 37oC. Slides were washed with PBS for 15 minutes, fixed in 2% 
paraformaldehyde at room temperature for 10 minutes, dehydrated through ethanol series, 
and air-dried briefly. Slides were then hybridized to a TRAMA-labeled (CCCTAA)3 
PNA probe (Panagene), then counterstained with DAPI. Z-stack images were captured 
and deconvoluted using Axiovision 4.6.3 software on a fluorescence microscope 
(Axiovert 200M; Carl Zeiss). 
 
Detection of oxidative base lesions in telomeres  
Identification of oxidative base lesions in telomeres was performed as previously 
described (236) with modifications. In brief, DNA was isolated from mouse liver or 
primary MEFs by salting out. 4 µg of DNA was treated with HinfI and RsaI restriction 
enzyme at 37°C overnight. The reaction was heated at 65°C for 15 minutes and then 
divided into two equal portions; one was treated with 8 units of E. coli 
formamidopyrimidine-DNA glycosylase (Fpg) (New England Biolabs) and another was 
treated with a mock buffer at 37°C for 30 minutes. Fpg was inactivated by heating at 
60°C for 15 minutes. Genomic single-stranded DNA fragments were separated on 1% 
alkaline agarose gel according to their sizes, treated with UV light, then transferred to a 
nylon membrane. Single-stranded telomere DNA fragments were detected by 32P-labeled 
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(CCCTAA)4 probe and visualized by autoradiography. ImageQuant software was applied 
in quantifying DNA cleavage in mock and Fpg-treated samples. A grid object was 
created as a single column with multiple rows and was placed over the lane 
corresponding to the molecular size markers. The density measurement was conducted in 
each row in which each marker was recorded. The mean length (ML) was calculated as a 
center of mass and expressed in kb: ML=Σ (MWi x ODi)/ Σ (ODi), in which MWi is the 
length of the telomeric DNA at each row and ODi is the densitometer output at each row. 
The frequencies of Fpg-sensitive lesions in a sample were calculated based on ML values 
in Fpg- and mock-treated samples: lesions = (ML untreated /ML treated) -1, in which ML 
is expressed in kb. Fold-changes in each sample were further normalized with respect to 
the number of Fpg-sensitive lesions in a control. 
 
4.3 Results 
Ogg1 deficient mouse tissues and primary MEFs under low oxygen tension display 
telomere lengthening 
Ablation of OGG1 function in S. cerevisiae can cause telomere elongation 
(13,237). Since OGG1 is conserved from S. cerevisiae to mice, we investigated the 
impact of Ogg1 deficiency on telomere length in mice. Mouse bone marrow cells were 
freshly isolated from 1-3 month old mice and analyzed by Q-FISH. Compared to the wild 
type, Ogg1-/- mouse bone marrow displayed higher mean and median telomere signal 
intensities (Figure 4.1). Similar results were obtained from bone marrow cells from 12 
month old mice (Figure 4.2). This observation was further confirmed by Flow-FISH, 
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Figure 4.1 – Telomere length in hematopoietic cells freshly isolated from wild type and Ogg1
-/-
 mice. 
Q-FISH analysis of metaphase spreads of the mouse bone marrow cells from wild type and Ogg1-/- mice (n=6). (A) Representative metaphase spreads of wild 
type and Ogg1-/- mouse bone marrow cells showing DAPI staining (blue, upper panel) and telomere fluorescence signals (red, upper panel; white, lower panel). 
Representative quantitative measurement and dynamic range of telomeric DNA signal intensity at individual chromosome ends in a wild type and an Ogg1-/- 
mouse are shown as histogram (B) and box-plot (C). An increase in telomere signal intensity was repeatedly observed in Ogg1-/- mice, compared to age-matched 
wild type mice (1.5-, 1.3-, 1.2-fold increase in three pairs of mice, respectively). 
 




Figure 4.2 – Q-FISH analysis of mouse bone marrow cells from 12-month-old wild type and Ogg1
-/-
 mice.  
(A) Representative metaphase spreads of wild type and Ogg1-/- mouse bone marrow cells showing DAPI staining (blue, upper panel) and telomere fluorescence 
signals (red, upper panel; white, lower panel). Quantitative measurement and dynamic range of telomeric DNA signal intensity at individual chromosome ends 
are shown as histogram (B) and box-plot (C). An increase in telomere signal intensity was observed in Ogg1-/- mice. *This figure is provided by Zhilong Wang. 
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showing that telomere signal intensity was moderately increased in Ogg1-/- mouse bone 
marrow cells from young and old animals (Figure 4.3A). Freshly isolated splenocytes 
from >3 month old Ogg1-/- mice also displayed higher telomere signal intensity than 
those of age-matched wild type mice (Figure 4.3A). Additionally, we examined telomere 
length in wild type and Ogg1-/- primary MEFs cultivated in 3% O2 that mimics the in vivo 
oxygen level in mice. Telomere signal intensity was moderately increased in Ogg1-/- 
primary MEFs as shown by Flow-FISH (Figure 4.3B) and, to a lesser extent, by Q-FISH 
(Figure 4.4).  
Next, we examined if deletion of Ogg1 could affect telomere capping in vivo. 
Freshly isolated mouse bone marrow cells and primary MEFs cultivated in 3% O2 were 
examined for the frequencies of chromosome end-to-end fusions and telomere signal free 
ends (SFEs).  Ogg1-/- mouse cells did not show any chromosome end-to-end fusions. The 
incidence of SFEs was low and not significantly different between wild type and Ogg1-/- 
mouse cells. Furthermore, Ogg1-/- mouse cells did not display spontaneous chromosomal 
abnormalities, e.g. chromosome breaks or fragments (Table 4.1). These data suggest that 
ablation of OGG1 function does not lead to telomere uncapping and chromosomal 
instability, but moderate telomere lengthening in mouse tissues and primary cells that are 
subjected to low levels of oxidative stress. 
 
High oxidative stress increases telomere attrition in Ogg1 deficient mouse cells 
To determine if high oxidative stress has the same or different impact on telomere 
length, primary wild type and Ogg1-/- MEFs were cultivated in 20% O2 or in the presence 
 




Figure 4.3 – Average telomere length in wild type and Ogg1
-/-
 mouse tissues and primary MEFs.  
Flow-FISH analysis of telomere signal intensity in freshly isolated bone marrow and spleen from wild type 
and Ogg1-/- mice (n=15) at different age (A), wild type and Ogg1-/- primary MEFs cultivated in 3% and 
20% oxygen for 6 passages (B), and wild type and Ogg1-/- splenocytes cultivated in 20% oxygen for 3 days 
(C). Telomere signal intensity was altered in Ogg1-/- mouse tissues and cells, compared to the wild type 
control.*This figure is provided by Zhilong Wang. 
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Figure 4.4 – Telomere length in primary MEFs cultivated in low or high oxidative environment.  
Q-FISH analysis of metaphase spreads of wild type and Ogg1-/- primary MEFs cultivated in 3% O2, 20% O2, or 3% O2 in the presence of 0.5 µM paraquat for 6 
passages. (A) Representative metaphase spreads of wild type and Ogg1-/- primary MEFs cultivated in 20% O2. Loss of telomere signals at chromosomes or 
chromatids were more frequently observed in Ogg1-/- MEFs (see enlarged chromosomes in boxes). (B) Representative histogram of dynamic range of telomeric 
DNA signal intensity at individual chromosome ends in a wild type and an Ogg1-/- primary MEF line. In comparison to wild type MEFs, slight increase in 
telomere signal intensity was repeatedly detected in Ogg1-/- MEFs in 3% O2 (approximately 1.1- fold increase in three pairs of MEF lines); and decreased 
telomere signal intensity and increased SFEs (see arrow) were repeatedly observed in Ogg1-/- MEFs cultivated with 20% O2 (2-, 1.7-, and 1.4-fold decrease in 
three pairs of MEF lines, respectively) and 0.5 µM paraquat (1.8-, 1.3-, and 1.2- fold decrease in three pairs of MEF lines, respectively). *This figure is provided 
by Zhilong Wang.
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Table 4.1 – Frequencies of chromosomal and telomeric abnormalities in wild type and Ogg1-/- bone 
marrow cells and primary MEFs 
 
Cell types Chr. Fragment & 
Breaks 
End-to-end fusion SFEs 
Bone marrow 
Wild type 0% (0/1919) 0% (0/1919) 0.4% (7/1919) 
Ogg1
-/-
 0% (0/1980) 0% (0/1980) 0.7% (14/1980) 
Primary MEFs (3% O2) 
Wild type 0% (0/1087) 0% (0/1087) 3.2% (35/1087) 
Ogg1
-/-
 0% (0/1140) 0% (0/1140) 4.1% (47/1140) 
Primary MEFs (20% O2) 
Wild type 0.1% (1/846) 0% (0/846) 4.5% (38/846) 
Ogg1
-/-
 0.7% (7/946) 0.11% (1/946) 8.4% (79/946)* 
Primary MEFs (0.5 µM paraquat) 
Wild type 0.1% (1/993) 0.1% (1/993) 4.1% (41/993) 
Ogg1
-/-
 0% (0/983) 0.2% (2/983) 18.6% (183/983)* 
 
*Number of abnormal events/total chromosomes. SFEs: telomere signal free ends. The data were obtained 
from metaphase spreads and Q-FISH analysis of different mice (n=6) or MEF lineages of each genotype 
(n=6). * p-value between wild type and Ogg1-/- yielded a statistical difference in indicated categories. 
^This table is provided by Zhilong Wang. 
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of 0.5 µM of paraquat (an oxidant). After six passages, they were evaluated for telomere 
length by Q-FISH and Flow-FISH. Surprisingly, under these conditions Ogg1-/- MEFs 
showed reduced telomere signal intensity, in comparison to wild type MEFs (Figures 
4.3B and 4.4). In addition to overall reduction in telomere signal intensity, Ogg1-/- MEFs 
had increased number of chromosomes and chromatids without detectable telomere 
signals (referred to SFEs and sister telomere loss, STL, respectively) (Figure 4.4 and 
Table 4.1). Notably, wild type MEFs also showed reduced telomere signal intensity after 
prolonged exposure to 20% O2 and 0.5 µM paraquat, in comparison to 3% O2. 
Nevertheless, they had less degree of telomere loss than Ogg1-/- MEFs (Figure 4.4). 
Similarly, subcultured Ogg1-/- mouse splenocytes and bone marrow cells showed reduced 
telomere signal intensity than wild type splenocytes, after being exposed to 20% O2 for 
the period of three days or to 200 µM paraquat for 16 hours, respectively (Figures 4.3C, 
4.5 and 4.6). Collectively, these results suggest that high oxidative stress increases 
telomere attrition in Ogg1-/- mouse cells.  
 
Telomere recombination is altered in Ogg1 deficient mice 
8-oxoG in telomeric DNA attenuates binding by telomere binding proteins (112), 
which may consequently evoke undesirable telomere recombination (29,197). On the 
other hand, Ogg1 deficiency may hamper telomere recombination (238). We thus 
examined the frequencies of telomere sister chromatid exchange (T-SCE) in wild type 
and Ogg1-/- mouse cells using CO-FISH (Figure 4.7A and 4.7B, and (50)). Freshly 
isolated Ogg1-/- bone marrow cells showed moderately increased T-SCEs (1.12 ± 0.25% 
 




Figure 4.5 – Q-FISH analysis of telomere length in activated mouse splenocytes cultivated in 20% O2. 
(A) Representative metaphase spreads of wild type and Ogg1-/- mouse splenocytes. Quantitative measurement and dynamic range of telomeric DNA signal 
intensity at individual chromosome ends are shown as histogram (B) and box-plot (C). A decrease in telomere signal intensity was observed in mouse Ogg1-/- 
splenocytes. Arrows: chromosome ends without detectable telomere signals.
 




Figure 4.6 – Q-FISH analysis of telomere length in mouse bone marrow cells subcultured with paraquat.  
(A) Representative metaphase spreads of wild type and Ogg1-/- mouse bone marrow cells. Quantitative measurement and dynamic range of telomeric DNA signal 
intensity at individual chromosome ends are shown as histogram (B) and box-plot (C). A decrease in telomere signal intensity was observed in mouse Ogg1-/- 
bone marrow cells. 
 
- 94 - 
 
 
Figure 4.7 – T-SCEs and telomere lagging or leading strand loss in wild type and Ogg1
-/-
 mouse cells. 
(A) A schematic presentation of CO-FISH. In brief, newly synthesized strands are removed, leaving 
parental strands to be detected by TRAMA-labeled (TTAGGG)
3 PNA probe (red color) and FITC-labeled 
telomere (CCCTAA)
3 PNA probe (green color). In an event of T-SCE, an end shows telomere signals in 
both green and red. In the event of collapse in telomere lagging strand synthesis, an end displays loss or 
reduction in telomere signal intensity in lagging strand. (B) Representative metaphase spreads of wild type 
and Ogg1-/- primary MEFs showing DAPI staining (blue), leading strand telomere fluorescence signals 
(red) and lagging strand telomere fluorescence signals (green). Arrow head: T-SCEs. Arrow: telomere 
lagging strand loss. *: telomere leading strand loss. (C) The frequencies of T-SCEs in freshly isolated wild 
type and Ogg1-/- mouse bone marrow cells (left panel) and primary MEFs cultured in 3% O2 or 20% O2 
(right panel). (D) The frequencies of telomeric loss in either telomere lagging or leading strand or both 
strands within a chromosome in wild type and Ogg1-/- primary MEFs cultured in 3% O2 or 20% O2. When 
cultivated in 20% O2, Ogg1
-/- MEFs showed significant increase in lagging strand loss, compared to wild 
type MEFs. *This figure is provided by Zhilong Wang. 
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and 2.82 ± 0.57% T-SCEs/chromosome in wild type and Ogg1-/-, respectively, p<0.001) 
(Figure 4.7C). In 3% O2 primary Ogg1
-/-
 MEFs displayed slight yet insignificant increase 
in T-SCE events (2.35 ± 0.08% and 3.28 ± 0.35% T-SCEs/chromosome in wild type and 
Ogg1
-/- respectively, p=0.06) (Figure 4.7C). In 20% O2 primary Ogg1
-/- MEFs, however, 
had fewer T-SCEs than the wild type (5.98 ± 0.52 % and 9.43 ± 0.51% T-
SCEs/chromosome in Ogg1-/- and wild type, respectively, p<0.001) (Figure 4.7C). These 
results suggest that deletion of Ogg1 may induce or inhibit telomere recombination, 
possibly depending on the level of oxidative stress.     
  
Telomerase activity is not altered in Ogg1 deficient mice 
Telomerase plays a key role in telomere elongation (2). Telomere lengthening in 
ogg1-deleted S. cerevisiae is dependent on telomerase (13). We therefore examined if 
telomerase activity was altered in Ogg1-/- mice. No detectable differences in telomerase 
activity were observed between wild type and Ogg1-/- mouse bone marrow cells by qT-
PCR TRAP assay (Figure 4.8). Telomere lengthening is therefore unlikely through 
enhanced telomerase activity in Ogg1-/- mice; however, we cannot exclude the possibility 
that there is an increased accessibility of telomerase to telomeres in Ogg1-/- mice. 
 
High oxidative stress enhances telomeric DNA strand breaks in Ogg1 deficient 
primary MEFs 
Previous studies suggest that oxidative stress-induced SSBs could result in 
telomere shortening (105). In addition, oxidative base damage in the vicinity of DNA 
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Figure 4.8 – Telomerase activity in wild type and Ogg1
-/-
 mouse bone marrow cells.  
qT-PCR analysis was performed on bone marrow cell lysate at indicated concentration. The Ct value was 
converted into log value. A comparable telomerase activity was detected in wild type and Ogg1-/- mouse 
bone marrow cells. 
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breaks can impose hindrance for resolving DNA ends (139,238-240). Under high oxygen 
tension, Ogg1-/- mouse cells displayed telomere attrition (Figures 4.3 and 4.4). It is 
unclear if oxidative stress-induced DNA strand breaks can accumulate in telomeres due 
to unrepaired oxidative base lesions and contribute to telomere attrition in Ogg1-/- mouse 
cells. We thus examined the frequencies of genomic and telomeric DNA strand breaks in 
wild type and Ogg1-/- primary MEFs cultivated in 20% O2. γH2AX and XRCC1 are 
known to form foci at the sites of double strand breaks (DSBs) and SSBs, respectively 
(241,242), and formation of γH2AX and XRCC1 foci were therefore used as markers for 
DSBs and SSBs in the genome and telomeres.  
γH2AX foci were detected in late passage wild type and Ogg1-/- MEFs by indirect 
immunofluorescence. A greater fraction of Ogg1-/- MEFs showed > 3 γH2AX foci 
compared to the wild type (approximately 12% wild type and 38% Ogg1-/- MEFs, 
respectively) (Figure 4.9A). γH2AX foci were detected in telomeres in both wild type 
and Ogg1-/- MEFs by TEL-FISH, and the latter had approximately 2-fold more telomeric 
γH2AX foci (Figure 4.9B and 4.9C). To further clarify telomeric γH2AX foci, we 
examined the formation of 53BP1 foci in telomeres by TEL-FISH (43). The 53BP1 foci 
were also detected in telomeric DNA in Ogg1-/- MEFs (Figure 4.10). Similarly, XRCC1 
foci were found in the genome in both wild type and Ogg1-/- MEFs (Figure 4.9D), and 
Ogg1
-/- MEFs had higher occurrence of telomeric XRCC1 foci (Figure 4.9E and 4.9H). 
This phenotype was further enhanced when MEFs were treated with 10 µM hydrogen 
peroxide for 24 hours (Figure 4.9F and 4.9G). Under low oxygen tension (i.e. 3% O2), the 
frequencies of γH2AX and XRCC1 foci were low, and no detectable difference was 
 




Figure 4.9 – DNA damage foci in wild type and Ogg1
-/-
 primary MEFs cultivated in high oxidative 
environment.   
(A-C) γH2AX in late passage primary MEFs cultivated in 20% O2. A: Percentage of γH2AX positive cells 
was divided into subgroups according to the number of foci in a cell. B: Percentage of γH2AX foci in 
telomeres. C: A representative Ogg1-/- primary MEF, showing DAPI staining (grey), γH2AX foci (green), 
and telomere fluorescence signals (red). Colocalization of γH2AX staining with telomere signal was 
illustrated in enlarged images at far right. (D-H) Genomic or telomeric XRCC1 foci in primary MEFs. D 
and E: MEFs cultivated in 20% O2. F and G: MEFs exposed to 10 µM H2O2 for 24 hours. Average genomic 
XRCC1 foci /cell (D or F) and percentage of XRCC1 foci in telomeres (E or G) were indicated. H: A 
representative Ogg1-/- primary MEF cultivated in 20% O2, showing DAPI staining (grey), XRCC1 foci 
(green), and telomere fluorescence signals (red). Colocalization of XRCC1 signals with telomere signals 
was illustrated in enlarged images at far right.*This figure is provided by Zhilong Wang.
 




Figure 4.10 – 53BP1 foci are detected in telomeres in Ogg1
-/-
 MEFs.  
Upper panel: a representative Ogg1-/- late passage primary MEF, showing DAPI staining (blue), 53BP1 foci 
(green), and telomere fluorescence signals (red). Arrows: colocalization of 53BP1 staining with telomere 
signal.  Lower panel: a primary MEF negative for 53BP1 foci. 
*This figure is provided by Zhilong Wang. 
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observed between wild type and Ogg1-/- MEFs (data not shown). Collectively, these 
results support the notion that oxidative stress can increase DSBs and SSBs in the 
genome and telomeres when Ogg1 is deleted.  
 
High oxygen tension leads to preferential telomere strand loss in Ogg1 deficient 
primary MEFs 
CO-FISH has been applied to detect defects in telomere lagging and leading 
strand loss, and it is proposed that such loss is caused by defects in lagging or leading 
strand synthesis (Figure 4.7A and 4.7B, and (243,244)). Because oxidative stress can 
increase DNA strand breaks in Ogg1-/- MEFs, it is possible that these DNA strand breaks 
may block telomere DNA replication and contribute to telomere attrition in Ogg1-/- MEFs. 
We therefore examined the frequencies of telomere lagging and leading strand loss in 
wild type and Ogg1-/- primary MEFs by CO-FISH. No significant difference in leading 
and/or lagging strand loss was detected between wild type and Ogg1-/- MEFs under low 
oxygen tension (3% O2); however, under high oxygen tension (20% O2), more telomere 
loss was found in the lagging strand in Ogg1-/- MEFs (1.80 ± 0.37% and 3.50 ± 0.44% 
lagging strand losses/chromosome in wild type and Ogg1-/- MEFs, respectively, p<0.001) 
(Figures 4.7D and 4.11). These results indicate that oxidative stress-induced oxidative 
DNA lesions (possibly DNA strand breaks with adjacent oxidized guanines) may 
preferentially affect lagging strand DNA synthesis in telomeres in Ogg1-/- MEFs.  
Aside from telomere lagging or leading strand synthesis defect, other factors (e.g. 
DNA strand breaks and nucleolytic degradation in a telomere strand) may also contribute 
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Figure 4.11 – CO-FISH analysis of primary Ogg1
-/-
 MEFs.  
Individual images represent leading-strand (red) and lagging-strand (green) telomere fluorescence signals. 
Chromosomes without telomere loss had two telomere fluorescence signals in each image. Merged images 
were shown at the bottom. *This figure is provided by Zhilong Wang. 
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to the loss of telomeric repeats in a telomere strand. To distinguish these possibilities, we 
employed a two-color telomere-FISH that detects telomere signals in G and C strands of 
a chromatid (Figure 4.12A and 4.12B). In 20% O2, loss of telomere signals in both G and 
C strands of a chromatid (or loss of a chromatid) was detected in wild type and Ogg1-/- 
MEFs, with higher frequencies in the latter (1.57 ± 0.47% and 3.32 ± 0.11% telomere 
chromatid losses/chromosome in wild type and Ogg1-/- MEFs, respectively, p<0.001) 
(Figure 4.12B and 4.12C). However, loss of telomere signal intensity in one of the 
telomere strands, either G or C strand was also evident in wild type and Ogg1-/- MEFs 
(Figure 4.12B and 4.12C), but G-strand loss appeared to be more prominent and was 
approximately 2-fold higher in Ogg1-/- MEFs (Figure 4.12C). Thus, telomere loss 
occurred in either one strand or both strands of a chromatid in Ogg1-/- MEFs. These 
results suggest that besides telomere replication defects, DNA breakage/degradation-
mediated strand loss may have occurred in telomeres in Ogg1-/- MEFs. Because only the 
G-rich strand of telomeric DNA can harbor oxidized guanines, this may explain why 
oxidative DNA damage induces telomere attrition with strand bias. 
 
Deletion of mouse Ogg1 is associated with increased oxidative guanine lesions in 
telomeres in vivo 
Guanine has a lower oxidation potential compared to other bases, and triple 
guanines, composed of the mammalian telomere repeats, have an even lower oxidation 
potential (245,246). Consistently, it has been found that triple guanines in telomere 
repeats are prone to oxidative damage in vitro (106-108,223). To determine the level of 
 
- 103 - 
 
 
Figure 4.12 – Preferential telomere loss in G strands in primary Ogg1
-/-
 MEFs cultivated in 20% 
oxygen.  
(A) A schematic presentation of a two-color Q-FISH measurement of telomere signals on G- and C-strands 
by TRAMA-labeled (TTAGGG)
3 PNA probe (red color) and FITC-labeled telomere (CCCTAA)3 PNA 
probe (green color). (B) Representative metaphase spreads of wild type and Ogg1-/- primary MEFs, 
showing DAPI staining (blue), C-strand (red), and G- strand (green) telomere fluorescence signals. (C) 
Percentage of telomere losses / chromosome in MEFs. Arrows: chromosomes with loss or reduced telomere 
signal intensity in G-strand. Arrowheads: chromosomes with loss or reduced telomere signal intensity in C-
strand. *: chromosomes with loss of telomere signals in both G- and C-strands in a chromatid. ^This figure 
is provided by Zhilong Wang. 
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guanine oxidation in telomeres in vivo, genomic DNAs from wild-type and Ogg1 
deficient mouse liver and primary MEFs were digested with restriction enzymes and then 
examined for their sensitivity to E. coli Fapy DNA glycosylase (Fpg). Fpg excises 
oxidized guanines, resulting in abasic sites that are further processed by the lyase activity 
of Fpg to create SSBs (115,224). The extent of increased smaller single stranded 
telomeric DNA fragments is proportional to the amount of Fpg-sensitive lesions present 
within the telomeric DNA and can be extrapolated to estimate the number of lesions 
(Figures 4.13A and 4.14, and (236)).  
To validate the method, genomic DNA was treated in vitro with increasing 
concentration of hydrogen peroxide (H2O2) plus Cu
2+. Higher doses of H2O2 treatment 
caused detectable increase of Fpg-sensitive lesions (Figure 4.13B), demonstrating that the 
method is feasible in estimating Fpg-sensitive lesions in telomeres. Next, we measured 
Fpg-sensitive lesions in telomeres in mouse livers derived from wild type and Ogg1-/- 
mice. The level of telomeric Fpg-sensitive lesions was not significantly changed in the 
hepatocytes from 2- and 8-month old wild type mice; however, telomeric Fpg-sensitive 
lesions were elevated in the hepatocytes from 8-month old Ogg1-/- mice (Figure 4.13C). 
We also measured oxidative guanine lesions in primary MEFs during prolonged culture 
under low and high oxygen tensions (3% O2 and 20% O2). Higher levels of Fpg-sensitive 
lesions were observed in primary MEFs under high oxygen tension, and Ogg1-/- MEFs 
harbored more lesions than wild type MEFs (Figure 4.13C). Collectively, these results 
indicate that ablation of OGG1 function can increase oxidative guanine lesions in 
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Figure 4.13 – Increased level of Fpg-sensitive DNA lesions in telomeres in Ogg1 deficient mouse 
tissues and cells.   
(A) Schematics of telomere guanine damage detection. A telomere DNA fragment with guanine lesions is 
converted into smaller fragments due to Fpg’s treatment. M.W: molecular marker from high (top) to low 
(bottom) molecular weight. (B) Validation of the method. Mouse genomic DNA was treated in vitro with 
increasing concentration of hydrogen peroxide (H2O2) plus Cu
2+, followed by restriction enzyme and Fpg 
treatment. Telomeric DNA fragments with (+) or without (-) Fpg treatment were detected by Southern blot 
analysis using a radio-labeled telomere probe. Higher doses of H2O2 treatment caused Fpg-dependent 
increase of shorter telomere DNA fragments and more detectable Fpg-sensitive sites in the telomeric DNA. 
(C) Detection of telomeric base lesions in wild type and Ogg1-/- mouse tissues and primary MEFs. DNA 
was extracted from wild type and Ogg1-/- liver tissues from 2 and 8 month old  mice (left panel), late 
passage primary MEFs cultured in 3% and 20% O2 (middle panel), or early passage primary MEFs 
collected at 0 hour and 8 hours after exposure to 500 µM H2O2 treatment for 60 minutes (right penal). In 
each experiment, fold changes in telomere base lesions in a testing sample were derived by normalizing the 
number of Fpg-sensitive lesions in the testing sample to that in a wild-type control. The control value was 
set to 1. The fold change represented average value from at least three independent experiments. M: month. 
H: hours. (D) Representative image of primary MEFs recovered from H2O2 treatment. 8 hours after 
exposure to H2O2, Ogg1
-/- MEFs still showed smaller telomere DNA fragments after Fpg treatment, while 
wild type MEFs displayed similar distribution of telomere DNA fragments with or without Fpg treatment.
 




Figure 4.14 – Schematics of telomerase base lesion calculation.  
(A) Gel profiles of wild type and Ogg1-/- mouse cells with or without Fpg treatment. (B) The density in each data point was measured by densitometer and 
ImageQuant software and collected into a grid. (C) The histogram illustrates a density profile of a grid and the corresponding molecular size at each data point. 
The mean length (ML) was calculated as a center of mass, and the frequencies of Fpg-sensitive lesions in a sample were based on ML values, as described in 
Methods.
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telomeres in mouse tissues with aging or in primary MEFs during prolonged culture or 
under oxidative stress conditions.   
To further verify if OGG1 participates in oxidative guanine repair in telomeres in 
vivo, early passage wild type and Ogg1-/- primary MEFs were exposed to 500 µM 
hydrogen peroxide for 60 minutes and then allowed to recover for 8 hours. Immediately 
after hydrogen peroxide treatment (0 hour), high levels of Fpg-sensitive lesions were 
detected in wild type and Ogg1-/- MEFs, compared to untreated MEFs. Eight hours after 
removal of hydrogen peroxide, Fpg-sensitive lesions were significantly reduced in wild 
type MEFs; in contrast they remained at a higher level in Ogg1-/- MEFs (Figure 4.13C 
and 4.13D). Thus, Ogg1-/- MEFs were inefficient in the repair of hydrogen peroxide-
induced Fpg-sensitive lesions in telomeres, while wild type MEFs repaired these lesions 
with high efficiency. These results demonstrate that OGG1 is involved in the repair of 
oxidative guanine lesions in telomeres in vivo.      
 
4.4 Discussion 
BER is the primary DNA repair pathway for the repair of oxidative base lesions. 
Here, we studied the impact of Ogg1 deficiency on telomeres in mammalian cells. We 
found that ablation of OGG1 function resulted in increased oxidative guanine lesions in 
telomeres in mice with aging or in primary MEFs during prolonged culture or cultivated 
in  a high oxidative environment. In addition, lack of Ogg1 led to telomere length 
alteration that was dependent on the level of oxidative stress. Furthermore, deletion of 
Ogg1 caused altered recombination, increased DNA strand breaks, and preferential strand 
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loss in telomeres. Our data support that oxidative guanine lesions affect telomere 
integrity and that the OGG1-initiated BER pathway plays an important role in telomere 
base damage repair and telomere maintenance in mammals.  
Ogg1 deficient mouse cells showed moderate telomere lengthening under low 
oxygen tension (e.g. in tissues or 3% O2); however, they displayed accelerated telomere 
shortening under high oxygen tension (20% O2) or with paraquat treatment. This 
observation suggests that the level and types of oxidative DNA damage in telomeres may 
affect the outcome of telomere length. Several possibilities may contribute to the 
telomere length alteration in Ogg1 deficient mouse cells. 
8-oxoG can directly disrupt telomeric DNA binding by TRF1 and TRF2  (112), 
and unrepaired 8-oxoG can lead to GC to TA transversions (228). The affinity of 
telomere binding proteins to telomeric DNA is sequence-specific and can be altered by 
mutations in telomeric DNA (247). Thus, both base lesions and base lesion-induced 
mutations may affect the association of telomere binding proteins to telomeres. Opresko 
et al have previously shown that the level of 8-oxoG in telomeres adversely affects 
binding by telomere binding proteins (112). Thus, the number of oxidative base lesions 
and mutations may determine the severity of telomere binding protein depletion in 
telomeres. It is known that reduced binding or severe loss of telomere binding proteins in 
telomeres can lead to different telomere phenotypes; the former causes telomere 
lengthening and the latter results in telomere uncapping (3). Thus, when few base lesions 
affect telomeric DNA repeats, they may moderately reduce telomere binding proteins in 
telomeres, which could liberate the negative regulation of telomere binding proteins on 
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telomerase and consequently increase telomerase-dependent telomere repeat additions. 
Our studies in S. cerevisiae support this notion, in which telomere lengthening in ogg1-
deleted S. cerevisiae is dependent on telomerase-mediated telomere elongation (13). On 
the other hand, once oxidized bases accumulate to a certain level in telomeres, they may 
severely deplete telomere binding proteins in telomeres and result in telomere uncapping. 
Uncapped telomeres can become targets for nucleolytic degradation and hence cause 
telomere shortening. 
When exposed to 20% O2 or hydrogen peroxide, Ogg1 deficient mouse cells 
showed increased incidences of SSBs and DSBs in telomeres, evident by XRCC1 and 
γH2AX foci formation in telomeres. These DNA strand breaks can represent an obstacle 
for DNA replication. Furthermore, base lesions in the vicinity of DNA strand breaks can 
somehow accelerate end resection, possibly by stimulating an endonuclease activity close 
to the breaks (248). As a result, these DNA defects may ultimately lead to telomere 
shortening in Ogg1 deficient mouse cells. However, fewer DNA strand breaks may also 
arise in Ogg1 deficient mouse tissues and partially inhibit DNA replication, which could 
consequently enhance telomerase pathway and induce telomere elongation (249,250). 
DNA strand breaks in Ogg1 deficient mouse cells may arise in telomeres by several 
means. High oxygen tension has been shown to cause detectable levels of SSBs in 
telomeres, especially in the G-strand (105). Since the presence of oxidative guanine 
damage in the vicinity of DNA breakages may impose a hindrance to the resolution of 
DNA ends (139,238-240), they may possibly inhibit repair of DNA strand breaks in 
telomeres. If adenine is incorporated opposite unrepaired 8-oxoG, removal of adenine by 
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the MYH DNA glycosylase and subsequent abasic site processing can lead to SSBs in the 
C-strand (233). SSBs may also be indicative of increased partial repair products of back-
up DNA glycosylase activity, e.g. Neil1 (251). 
Previous reports demonstrate that telomere lagging strand loss can be detected  in 
WRN and FEN1 mutant cells via CO-FISH, which may reflect lagging strand telomere 
synthesis defects (243,244). Because oxidative guanine lesions are located at G-strand in 
telomeres, they may preferentially inhibit repair of SSBs in this strand. As a result, 
lagging strand telomere synthesis may be affected. Indeed, Ogg1 deficient MEFs showed 
an increase in telomere lagging strand loss by CO-FISH analysis. This result suggests that 
oxidative guanine damage and/or its negative effect on the repair of telomere strand 
breaks may perturb lagging strand DNA synthesis in telomeres. Telomere lagging strand 
loss may also result from SSBs in G-strand along with loss of distal telomeres or 
nucleolytic degradation. In fact, the two-color Q-FISH showed that telomeric G-strand 
loss can occur alone without a loss of its complementary C-strand in Ogg1-/- MEFs, 
supporting the latter possibility.  
Besides changes in telomere length, the incidence of T-SCEs either increased or 
decreased in Ogg1 deficient mouse cells, which was reversely associated with the level of 
oxidative stress. Several possibilities may account for the altered telomere recombination 
in Ogg1 deficient mouse cells. First, variable levels of oxidative base damage may have 
different impact on recombination activity. For example, recombination rates are 
substantially increased in BER deficient yeast cells harboring low levels of oxidative 
DNA damage in the genome, and it has been postulated that a moderately damaged 
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genome could promote illegitimate recombination that serves as a compensatory response 
in order to tolerate oxidative DNA damage (252). However, high density of oxidative 
base lesions can inhibit RAD52 annealing activity and thus result in reduced 
recombination resolution (238). Second, OGG1 can inhibit RAD52 strand annealing and 
exchange activity (238), and removal of OGG1 would therefore relieve this inhibition 
and activate the recombination pathway. Third, oxidized guanines may affect telomere 
recombination by disrupting shelterin’s association to telomeres. Previous studies 
demonstrate that telomere binding proteins prevent telomeres from becoming substrates 
for HR, and deletion of telomere binding proteins invokes T-SCE events (197,198). 
Because oxidative base lesions in telomeric DNA can attenuate binding by telomere 
binding proteins (112), it is possible that reduced binding of telomere binding proteins to 
telomeres may promote telomere recombination. Finally, increased telomere sister 
chromatid exchanges may associate with recombination repair of stalled or broken 
replication forks that might occur at the sites of oxidative bases and/or DNA strand 
breaks in telomeres.  
We found that oxidative guanine lesions in telomeres were elevated in older 
animals or in primary MEFs cultivated under oxidative stress conditions. Thus, oxidative 
damage on guanine bases can increase in telomeres in aging or by environmental 
oxidative stress. The level of Fpg-sensitive lesions in telomeres was increased in Ogg1-/- 
mouse liver and primary MEFs, in comparison to their wild type counterparts. These 
results indicate that OGG1 is involved in repairing oxidative guanine lesions in telomeres 
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in vivo. This view was further supported by the evidence that Ogg1-/- MEFs were 
defective in the repair of hydrogen peroxide-induced Fpg-sensitive lesions in telomeres. 
Oxidative stress-induced SSBs can cause telomere shortening in mammalian cells 
(101). Here, we report that another form of oxidative DNA damage, oxidative base 
lesions can induce either telomere lengthening or shortening, depending on the level of 
oxidative stress. In a given organism, telomere length is maintained via a balance 
between telomere elongation and shortening (2). It is possible that moderate oxidative 
base damage may favor the pathways for telomere lengthening (e.g. telomerase), while 
extensive oxidative base damage may attenuate telomere capping, telomere 
recombination, telomere replication, and the resolution of DNA strand breaks and 
ultimately result in telomere attrition (Figure 4.15). Telomere shortening has been linked 
to human aging and cancer development. Perhaps extensive base damage occurs in 
individuals with the conditions, such as defective BER and increased ROS levels (for 
example, chronic inflammation), which may consequently lead to accelerated telomere 
attrition, thus contributing to premature aging and cancer formation. 
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Figure 4.15 – The levels and types of oxidative DNA damage may determine telomere length alteration. 
Telomeres are normally capped by telomere protein complex which limit the access of telomerase to telomeres and prevent telomeres from evoking DNA 
damage response and becoming the subject of nucleolytic degradation and recombination. Under low oxidative condition, base damage is low and affects fewer 
telomeric DNA repeats, which may moderately reduce telomere protein complex in telomeres, thus causing increased telomerase-mediated telomere lengthening. 
High oxidative stress can, however, not only increase base damage but also induce DNA strand breaks, and the former may severely deplete telomere protein 
complex in telomeres and impose a hindrance to the resolution of DNA breaks. As a result, it may lead to telomere uncapping, increased telomere strand breaks, 
and nucleolytic degradation, hence causing telomere shortening. 
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Chapter 5: Investigating Factors that Influence Telomeric 
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All eukaryotic linear chromosomes consist of nucleoprotein complexes called 
telomeres. Telomeres are composed of extended tracts of short G-rich tandem repeat 
sequences, 5’-TTAGGG-3’, and a short terminal single-stranded 3’-overhang in humans 
and mice. Functional telomeres prevent chromosome termini from being recognized as 
broken DNA ends. On the other hand, dysfunctional telomeres, as a consequence of loss 
of telomere repeats or loss of protection by telomere-associated proteins, can trigger a 
DNA damage response and subsequently lead to genomic instability, cell proliferation 
defects, and cell death (4). 
Telomere length homoeostasis is maintained through interplay between 
telomerase extension, telomere replication, and telomere capping (53). Telomerase, a 
ribonucleoprotein complex, is essential in telomere length maintenance since it can 
anchor to the 3’-overhang and extend telomeric DNA repeats (2). All functional 
telomeres are coated with telomere-specific binding proteins (e.g., TRF1 and TRF2) and 
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their associated proteins, collectively known as the shelterin protein complex (253). With 
the aid of shelterin proteins, telomeres normally exist in a loop structure (also known as 
T-loop) with the 3’-single-stranded overhang invading the telomeric double-stranded 
DNA (22). Disruption of the T-loop and exposure of the 3’-overhang destabilizes the 
telomere since the “capped” telomere normally inhibits undesirable recombination and 
DNA damage response (3,183). Evidence indicates that shelterin proteins also regulate 
telomerase extension and efficient telomere replication (53,221,222,254).  
Genomic DNA is continuously exposed to DNA damaging agents through both 
endogenous (e.g., reactive oxygen species, ROS, as by-products of normal metabolism) 
and exogenous (e.g., physical and chemical agents such as γ- or UVA-irradiation) means. 
ROS can generate oxidative DNA lesions including oxidized bases and single-strand-
breaks (SSBs) (255). 7, 8-dihydro-8-oxogaunine (8-oxodG) is one of the most abundant 
and widely studied oxidative base lesions. If unrepaired, it is mutagenic and detrimental 
to cells since it results in guanine-to-thymine transversion mutations (256). The primary 
repair pathway responsible for removing such oxidative lesions is the base excision repair 
(BER) pathway. Briefly, 8-oxoguanine DNA Glycosylase (OGG1) initiates the BER 
pathway by removing the damaged guanine base, followed by incision, repair synthesis, 
and ligation by various members in the BER pathway to complete the repair process 
(115,257,258). OGG1 glycosylase activity on 8-oxodG modified substrates has been 
extensively studied. For instance, OGG1 can remove 8-oxodG opposite of cytosine 
efficiently (259) and prefers to work in a processive mode where OGG1 move from one 
substrate to adjacent substrate without disengaging from the DNA (140). OGG1’s 
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incision is affected by flanking sequences with preference for 5’-(C/G)me-FapyC-3’ 
(141). In addition, an opposing abasic site or SSBs towards the 3’ of the catalytic pocket 
can greatly reduce OGG1 incision activity (137-139). Furthermore, the position of 8-
oxodG in fork substrates can influence OGG1 incision activity (139).  
It has been proposed that oxidative DNA damage plays a role in telomere attrition 
in aging (260). Human cells with long telomeres show increased sensitivity to hydrogen 
peroxide, but not to etoposide and bleomycin, supporting the notion that telomeres are 
particularly vulnerable to oxidative damage (102). Several studies have shown that 
oxidative stress also induces oxidative DNA base damage preferentially at telomeric 
DNA in vitro. For example, oxidative damage is several-fold more efficient in inducing 
8-oxodG in oligonucleotides containing telomeric repeats than non-telomeric repeats, 
even though the latter have similar guanine content (106-108,261). However, it is yet to 
be determined if telomeric DNA is prone to oxidative damage in vivo. Oxidation of 
guanines can occur at either the 5’ or the middle guanine in GGG triplets (106-108). The 
consequence of oxidative guanine DNA damage has been investigated previously. The 
presence of 8-oxodG in telomeric nucleotides disrupts telomerase activity (111) and 
inhibits binding of TRF1 and TRF2 (112), respectively. Our recent studies imply that 
oxidative guanine damage can arise in telomeres in vivo, where it affects telomere length 
homeostasis, recombination, DNA replication, and DNA breakage repair. We also 
demonstrated that OGG1 is required for repairing oxidized guanines in telomeres and 
maintaining telomere integrity in budding yeast and mice (13,262).  
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Several mechanisms may contribute to the accumulation of oxidative guanine 
lesions in telomeres. It is possible that telomeric DNA repeats may favor guanine 
oxidation. In addition, oxidative guanine repair may be impeded by telomere specific 
factors (e.g., telomere special structures or telomere repeat binding proteins). In this study, 
we examined if telomeric DNA is prone to oxidative guanine damage in vivo and if 
telomere specific factors can affect OGG1 base incision activity in telomeres. Our data 
suggest that triplet guanines in telomeric repeats significantly contribute to the 
preferential accumulation of oxidative guanine damage in telomeres and the repair of 
oxidative guanine lesions in some telomere configurations can be problematic. 
 
5.2 Experimental Procedures 
Cell culture, induction of oxidative DNA damage, and genomic DNA isolation 
U2OS osteosarcoma cells were maintained in DMEM (Dulbecco’s modified 
Eagle’s Medium) growth medium supplemented with 10% fetal bovine serum (FBS) at 
37ºC in a 5% CO2 atmosphere. To induce oxidative DNA damage in vivo, cells were 
treated with 1 mM of menadione (Sigma Aldrich) in serum-free DMEM growth medium 
for 30 min, washed with PBS and incubated for additional 6 hours in serum-free DMEM 
growth medium before being collected (238). DNA isolation was performed as 
previously described (13,236,262). Briefly, freshly minced mouse kidney (C57BL/6 
genetic background) or U2OS cell pellets were incubated with DNA lysis buffer (10 mM 
Tris, pH 7.5, 400 mM NaCl, 1 mM EDTA, 0.5 % SDS, and 0.1mg/ml proteinase-K) 
over-night at 37°C. DNA was isolated using standard high salt extraction (6M NaCl with 
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vigorous shaking, followed by ethanol precipitation), treated with 100 µg/ml of RNase A 
(for 3 hours, followed by ethanol precipitation), and re-suspended in TE buffer (10 mM 
Tris, 1 mM EDTA, pH 7.2). For in vitro oxidative DNA damage induction, isolated 
mouse kidney DNA was treated with various concentrations of H2O2 and Cu
2+, followed 
by ethanol precipitation of the DNA as previously described (13). 
 
Measurement of oxidative base lesions 
Identification of oxidative base lesions in both telomeric and non-telomeric DNA 
was performed as described (13,236,262). In brief, 2 µg of DNA was treated with 10 
units each of HindfI and RsaI restriction enzymes (New England Biolabs) at 37°C for 3 
hours. Enzymes were inactivated by heating at 60°C for 20 minutes. Samples were 
treated with 8 units of E. coli formamidopyrimidine-DNA glycosylase (FPG) (New 
England Biolabs) at 37°C for 1 hour. Duplicate samples were treated with a mock buffer. 
FPG was inactivated by heating at 60°C for 15 minutes. Genomic single-stranded DNA 
fragments treated with FPG or mock buffer were separated on 0.8 % alkaline agarose gel 
and detected by Southern blot using 32P-labeled (AATCCC)4 or (CA) 12 probes and 
visualized by autoradiography. ImageQuant software was applied in quantifying DNA 
cleavage in FPG-treated and untreated samples. The mean length (ML) was calculated as 
a center of mass and expressed in kilobase. ML=Σ (MWi x ODi)/ Σ (ODi). MWi is the 
length of the DNA at each row, and ODi is the densitometer output at each row. The 
frequency of FPG-sensitive lesions was calculated as (ML untreated /ML treated) -1.   
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Enzyme and purified proteins 
Recombinant human 8-oxoguanine DNA glycosylase, OGG1 (α isoform, New 
England Biolabs) was used in the oligonucleotide incision assay. Recombinant histidine-
tagged human TRF1 and TRF2 proteins were purified using a baculovirus/insect cell 
expression system as previously described (112). 
 
Oligonucleotides 
Oligonucleotides used in this study are shown in Table 5.1 (Midland Certified, 
Midland TX). To construct duplex substrates, 8-oxoguanine modified oligonucleotides 
were first 5’ end labeled using [γ-32P] ATP (3000 Ci/mmol) with T4 polynucleotide 
kinase (New England Biolabs) and annealed to the template oligonucleotides in a 1:2 
molar ratio. Alternatively, 8-oxoguanine modified oligonucleotides were 3’ end labeled 
using [α-32P] ddATP (3000 Ci/mmol) with terminal deoxynucleotidyl transferase (New 
England Biolabs) and annealed to the template oligonucleotides in a 1:2 molar ratio. 
Annealing reactions were incubated at 95°C for 5 minutes and cooled to room 
temperature for 30 minutes. The D-loop substrate was prepared as described (263). 
Briefly, labeling the 5’ end of oligonucleotides (C3/C4) was conducted in the presence of 
[γ-32P] ATP (3000 Ci/mmol) and T4 polynucleotide kinase. Labeled oligonucleotides 
(C3/C4) was incubated with the complementary strand (C1) at 95°C for 5 minutes and 
cooled down stepwise (1.2°C/min) to 60°C, followed by addition of oligonucleotides 
(C2) and incubated at 60°C for 1 hour, which was cooled down stepwise (1.2°C /min) to 
25°C. 
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Table 5.1 – Oligonucleotides used in this study. Telomeric repeats are underlined and 7,8-dihydro-8-
oxogaunine modification is marked with bold X. 
Name Sequence (5’ → 3’) 
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Electrophoretic mobility shift assay (EMSA) 
EMSA was performed as previously described with minor modification (112,212). 
The reaction was conducted in a reaction mixture (10 µl) containing 1x Tel buffer (20 
mM HEPES, pH 7.9, 150 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 5% 
glycerol, 0.1% NP-40 and 100 µg/ml BSA) or 1x NEB #2 buffer (10 mM Tris-HCI, 50 
mM NaCl, 10 mM MgCl2, 1 mM DTT and 100 µg/ml BSA). The reactions were 
incubated with increasing amounts of TRF1 in ice for 20 minutes. Samples were resolved 
by electrophoresis on a 4.5% native polyacrylamide gel (acylamide/bis 37.5:1). Gels were 




OGG1 incision assays were performed in a reaction mixture (10 µl) containing 1x 
NEB #2 buffer (10 mM Tris-HCI, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT and 100 
µg/ml BSA). The reactions were incubated at 37°C for 15 min and terminated by addition 
of equal volume of 2x formamide loading buffer (95% (v/v) formamide, 20 mM EDTA, 
0.1% (w/v) bromophenol blue and xylene cyanol). Alternatively, reactions were 
incubated at 37°C for the time points indicated and terminated by adding equal volume of 
2x formamide loading buffer. Substrates were allowed to denature at 95oC for 10 min, 
followed by incubation in ice for 2 min. Samples were resolved by electrophoresis on a 
15% Polyacrylamide/7 M urea gel (National Diagnostic Inc.). Gels were visualized by 
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Phosphor-Imager and analyzed using the ImageQuantTM software (GE Bioscience). The 
percentage of incision was calculated as the amount of radioactivity present in the 
product band relative to the total radioactivity. For shelterin protein’s effect on hOGG1’s 
incision activity, incision assays were conducted in a reaction mixture (10 µl) containing 
1x Tel buffer (20 mM HEPES, pH 7.9, 150 mM KCl, 1 mM MgCl2, 0.1 mM EDTA, 0.5 
mM DTT, 5% glycerol, 0.1% NP-40 and 100 µg/ml BSA). Purified TRF1 was first added 
to the reaction mixture and incubated at room temperature for 20 minutes, followed by 
addition of hOGG1 and further incubation at 37°C for 15 minutes. 500 µg/µl of tRNA 




Telomeres are prone to oxidative guanine damage 
Evidence indicates that oxidative stress induces oxidative guanine damage 
preferentially in oligonucleotides with telomere repeats in vitro (106-108,261). To further 
investigate if telomeric DNA is also prone to oxidative DNA damage in vivo, the level of 
guanine oxidation was measured by examining Fpg-sensitive sites in telomeric 
(TTAGGG) and minisatellite (TG) regions of genomic DNA isolated from mouse kidney. 
Fpg excises oxidative guanine lesions and resulting abasic sites are further processed to 
single-strand-breaks via AP-lyase activity of Fpg (264). The extent of DNA 
fragmentation caused by Fpg reflects the frequency of oxidative DNA lesions, which 
appear as smaller molecular weight fragments after Fpg treatment (Figure 5.1). The mean 
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Figure 5.1 – In vitro exposure to increasing amount of oxidants leads to an increase in oxidative 
guanine damage preferentially in telomeres.  
Isolated genomic DNA was treated with indicated amounts of H2O2/Cu
2+, and subsequently with Fpg. 
Treated samples were separated using alkaline gel, and telomeric and non-telomeric DNA fragments were 
detected by Southern blot analysis using radiolabelled telomere or CA repeat probes. After the Fpg 
treatment, telomeric DNA migrated as smaller fragments proportionally to the amount of oxidative stress 
induced while modest difference in migration was observed in non-telomeric DNA fragments. 
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values of DNA fragments in Fpg-treated (+) and mock-treated (-) samples were applied 
to estimate the frequencies of oxidative DNA lesions in telomeric and TG minisatellite 
regions (236). More Fpg-sensitive sites were found in telomeric than in minisatellite 
DNA (approximately 45.36 ± 7.4 and 20.76 ± 1.36 sites/106 bp in telomeres and 
minisatellites, respectively) (Table 5.2). Similarly, a human cell line, U2OS displayed 
more Fpg-sensitive lesions in telomeric TTAGGG repeats compared to TG minisatellites 
(approximately 5.72 ± 0.51 and 3.76 ± 1.11 sites/106 bp in telomeres and minisatellites, 
respectively) (Table 5.2). Although both types of repeats harbor similar contents of 
guanines (50%), the fact that more oxidative guanine lesions were detected in telomeric 
DNA suggest that either triple guanines of telomeric DNA repeats or simply the repeat 
sequences themselves are prone to oxidation. More guanine damages in telomeres could 
also reflect that OGG1-initiated BER repair may be less effective in telomeres.  
To examine if telomeric DNA repeat sequences are more sensitive to oxidative 
stress, naked mouse kidney DNA was treated with increasing amounts of H2O2 and Cu
2+ 
in vitro (13), and the level of oxidized guanines (i.e., Fpg-sensitive sites) was examined 
for both telomeric and minisatellite regions of genomic DNA. Higher doses of H2O2 and 
Cu2+ treatment caused Fpg-dependent increase of shorter telomere DNA fragments 
(Figure 5.1, Left panel), whereas TG minisatellite DNA fragments displayed a moderate 
shortening under the same treatment conditions (Figure 5.1, Right panel). Accordingly, 
H2O2 and Cu
2+
 treatment increased the frequencies of Fpg-sensitive sites in telomeric 
DNA fragments significantly more than in TG minisatellite DNA fragments 
(approximately 303.04 ± 53.41 and 81.57 ± 11.88 sites/106 bp at high exposure in 
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Table 5.2 – The frequencies of FPG-sensitive sites/106 bp in telomeric (TTAGGG) and minisatellite (TG) 
regions of mouse kidney and U2-OS cells. 
 
*Because of semi-quantitative nature of the method, the frequency does not represent the absolute values of 
base lesions in these genomic regions. The values were derived from three independent experiments.
 Mouse Kidney U2-OS 
Telomeric DNA 45.36 ± 7.4* 5.72 ± 0.51 
Minisatellite DNA 20.76 ± 1.36 3.76 ± 1.11 
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telomeres and TG minisatellites, respectively) (Table 5.3). This observation suggests that 
telomere repeat sequences (possibly triple guanines or telomeric DNA repeats as a whole) 
can contribute to preferential guanine damage in telomeric DNA. 
To determine if there was differential oxidative guanine damage repair in 
telomeric DNA and TG minisatellites in vivo, U2OS cells were briefly treated with 1 mM 
of menadione, to induce high incidences of oxidative DNA damage, and allowed to 
recover for 6 hours according to previously described protocol (238). The level of 
oxidative DNA lesions was examined for both telomeric and TG minisatellite regions. 
The starting frequencies of Fpg-sensitive sites in telomeric DNA fragments and TG 
minisatellite were comparable immediately after the menadione treatment (approximately 
7.72 ± 1.75 and 9.56 ± 6.22 respectively) (Table 5.4). However, after 6 hours of recovery 
time, the Fpg-sensitive sites were undetectable in TG minisatellite while even higher 
frequencies of Fpg-sensitive sites were detected in telomeric DNA fragments (Not 
detected and approximately 14.25 ± 1.21 sites/106 bp in minisatellites and telomeres, 
respectively) (Table 5.4). These data suggest that OGG1-initiated BER may be less 
effective in telomeres in vivo, and thus oxidative DNA damage can accumulate in 
telomeres over time. 
 
The incision activity of α-hOGG1 is comparable in telomeric and non-telomeric 
double-stranded substrates 
Telomere special factors (e.g., telomeric DNA repeat sequences, telomere special 
structures, or telomere binding proteins) may affect the repair of oxidative guanine 
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Table 5.3 – The frequencies of FPG-sensitive sites/106 bp in telomeric (TTAGGG) and minisatellite (TG) 
regions of mouse kidney DNA after in vitro induction of oxidative stress. 
 
 
*Because of semi-quantitative nature of the method, the frequency does not represent the absolute values of 
base lesions in these genomic regions. The values were derived from three independent experiments.
   H2O2 (mM) 6 18 
 
     Cu2+ (µM) 2 8 
Telomeric DNA 137.88 ± 17.71* 303.04 ± 53.41 
Minisatellite DNA 68.69 ± 31.74 81.57 ± 11.88 
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Table 5.4 – The frequencies of FPG-sensitive sites/106 bp in telomeric (TTAGGG) and minisatellite (TG) 
regions of U2OS cells after menadione treatment plus 6 hours of recovery time. 
 
 
*Because of semi-quantitative nature of the method, the frequency does not represent the absolute values of 
base lesions in these genomic regions. ND= Not detectable. The values were derived from three 
independent experiments.  
 0 hour 6 hours 
Telomeric DNA 7.72 ± 1.75* 14.25 ± 1.21 
Minisatellite DNA 9.56 ± 6.22 ND 
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damage in telomeres and contribute to differential repair of oxidative guanine damage in 
telomeric and non-telomeric regions. To examine if triple guanines of telomeric DNA 
repeats or repeat sequences themselves affect oxidative guanine repair, we employed an 
in vitro α-hOGG1-incision assay. The α-hOGG1 enzyme is primarily responsible for 
removing 8-oxodG in the nucleus of human cells and its incision activity was examined 
on 8-oxodG containing double-stranded oligonucleotide substrates, with telomeric or 
non-telomeric DNA repeats harboring either one or triple guanines. Specifically, in 
telomeric-duplex-1 (TD1), the middle guanine of one of the telomere repeats was 
modified with 8-oxoguanine, whereas in non-telomeric-duplex-1 (NTD1) and non-
telomeric-duplex-2 (NTD2) 8-oxoguanine modification was surrounded by non-telomeric 
sequences (Table 5.1, Figure 5.2). Notably, NTD1 had two guanines flanking the 8-
oxodG to mimic triple guanines of telomeric DNA, whereas NTD2 was flanked by 
cytosine and adenine to mimic single 8-oxodG condition. These duplexes (0.5 nM) were 
incubated with serial dilutions (16, 32, 64, 128, or 256 nM) of α-hOGG1 and the 
percentage of incision product was measured and compared between telomeric and non-
telomeric DNA repeats containing oligonucleotide substrates. 16 nM (lowest 
concentration of enzyme) of α-hOGG1 was able to efficiently excise the substrates and 
the percentages of excised products increased with increase in enzyme concentration 
(Figure 5.3). The percentage of excised products from telomeric duplex TD1 (Lanes 1-6) 
were equivalent to non-telomeric duplex NTD1 (Lanes 7-12), which suggests that α-
hOGG1 can excise 8-oxodG from a triple guanine repeat (G8G, 8 refers to 8-oxodG) of a 
non-telomeric or telomeric duplex with similar efficiency. Moreover, the percentage of 
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Figure 5.2 – Double-stranded oligonucleotide substrates.  
Oligonucleotides modified with 8-oxodG were either 5’ end-labeled or 3’ end-labeled and annealed to the 
corresponding complementary strands. The bold X denotes the 8-oxodG modifications.  
 




Figure 5.3 – α-hOGG1 incision activity is comparable between telomeric and non-telomeric DNA 
repeats containing double-stranded substrates.  
Substrates (0.5 nM) were incubated alone (lanes 1, 7, and 13) or together with increasing concentrations of 
OGG1 (16, 32, 64, 128, or 256 nM, lanes 2-6, 8-12, and 14-18). No significant difference in incision 
activity was observed among these substrates. The percentage cut was plotted against α -hOGG1 
concentrations. Values and error bars represent the mean and SE from three independent experiments. 
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excised products was comparable between telomeric substrate TD1 and non-telomeric 
substrate (NTD2) with a single guanine (Lanes 13-18). Taken together, these studies 
suggest that triple guanines of telomeric DNA repeats and repeat sequences themselves 
do not impact OGG1 incision activity. 
 
α-hOGG1 prefers to excise the middle 8-oxodG base lesion in telomeric triplet 
guanines 
Our data suggest that a single 8-oxodG in telomeric substrates can be efficiently 
excised by α-hOGG1 in vitro. It is unclear whether multiple 8-oxodG base lesions in 
telomeric DNA substrates affect α-hOGG1 incision. The incision activity of α-hOGG1 
was examined on telomeric double-stranded oligonucleotide substrates with either single 
or triple 8-oxodG base modifications. Specifically, all the three guanines in one of the 
telomeric repeats was replaced by 8-oxodG in telomeric-duplex-2 (TD2) as opposed to 
one guanine in telomeric duplex TD1 (Table 5.1, Figure 5.2). α-hOGG1 was incubated 
with 0.5 nM of TD1 or TD2 duplexes in serial dilutions (16, 32, 64, 128, or 256 nM) and 
the percentage of incision product was measured between the two substrates. Our data 
indicate that the percentage of incision products was comparable between single and 
triple 8-oxodG containing substrates (Figure 5.4), which suggest that the number of 8-
oxodG within GGG of telomeric DNA repeats do not impact α-hOGG1 incision activity 
in vitro. 
Interestingly, the incision products of the triple 8-oxodG containing substrate TD2 
appeared more diffuse compared to that of the single 8-oxodG substrate (Figure 5.4, lanes 
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Figure 5.4 – α-hOGG1 incision activity is comparable between single and triple 8-oxodG containing 
double-stranded telomeric substrates.  
Substrates (0.5 nM) were incubated alone (lanes 1 and 7) or together with increasing concentrations of α -
hOGG1 (16, 32, 64, 128, or 256 nM, lanes 2-6 and 8-12). The incision products of triple 8-oxodG 
containing substrate was more diffused than single 8-oxodG containing substrate, indicated by three bars as 
opposed to two bars (arrows). Collectively, these incision products were similar between the two substrates. 
The percentage cut was plotted against α -hOGG1 concentrations. Values and error bars represent the mean 
and SE from three independent experiments. 
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6 and 12). This suggests that more than one of triple 8-oxodG was being excised, but it 
was unclear if there was a preferential incision of 8-oxodG at different positions of the 
telomeric triple G (GGG) repeat. Previous studies indicated that guanines in a telomeric 
DNA substrate are not equally susceptible to oxidative damage and that oxidative stress 
can induce base damage preferentially at 5’ or at the middle G in GGG of telomeric DNA 
repeats (107,108). Thus, we examined if there was preferential incision of 8-oxodG at the 
5’, the middle or the 3’ position in GGG of telomeric DNA repeats by α-hOGG1. To 
better visualize the incision products, the TD2 substrate was either 5’ labeled with γ-32P-
dATP or 3’ labeled with α-32P-ddATP.  To observe sequential incision of 8-oxodG in 
telomeric GGG, the TD2 substrate was incubated with a fixed amount (8 nM) of α-
hOGG1 enzyme. The reactions were stopped and collected at different time points (15 
sec, 30 sec, 1 min, 2 min, 4 min, and 8 min), and the incision products were separated to 
obtain a 1 bp difference. Three individual excised products were observed in 5’- and 3’- 
labeled substrates at the indicated positions (Figure 5.5, A and B). With 5’-end labeling, 
the middle 8-oxodG in telomeric GGG was being excised initially, followed by 8-oxodG 
on the 5’-site, and subsequently 8-oxodG on the 3’-site. After the initial incision of 
middle 8-oxodG, 8-oxodGs on the 5’-site was efficiently excised, however fewer 8-
oxodG at the 3’-site was removed (Figure 5.5C). Similarly, experiments with the 3’ 
labeled substrate also showed that the middle 8-oxodG in telomeric GGG was being 
excised initially, followed by 8-oxodG on the 5’-site, and subsequently 8-oxodG on the 
3’-site (Figure 5.5D). Taken together, these results suggest that there is preferential 
incision of 8-oxodG by α-hOGG1 at different positions in the telomeric DNA repeat. 
 




Figure 5.5 – α-hOGG1 prefers to excise middle 8-oxodG base lesion in telomeric DNA repeats. 
Substrates (0.5 nM) were incubated with fixed concentration of α -hOGG1 (8 nM) and collected at different 
time points (15 sec, 30 sec, 1 min, 2 min, 4 min, and 8 min, lanes 1-6 and 7-12). The middle 8-oxodG in 
telomeric GGG was excised initially, followed by 8-oxodG on the 5’-site, and subsequently 8-oxodG on the 
3’-site in both 5’ labeled (A and C) substrate and 3’ labeled (B and D) substrates. Arrows – The position of 
excised 8-oxodG. The peak α -hOGG1 incision activity was plotted against time points. Values and error 
bars represent the mean and SE from three independent experiments. 
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The position of the 8-oxodG lesion affects α-hOGG1 incision activity on a telomeric 
double-stranded substrate with a 3’-overhang 
Mammalian telomeres have unique structural features such as a 3’-overhang. The 
single-stranded nature of the 3’-overhang of the G-strand displaces the upstream G-strand 
and then base pairs with the C-strand creating a displacement loop or D-loop, which 
creates a circular structure known as the t-loop (3,22).  T-loop structure is known to mask 
the 3’-overhang from triggering DNA damage signaling and DNA repair (3). This 
telomeric structure may regulate the access or the function of BER proteins at telomeres. 
We examined the α-hOGG1 incision activity on 8-oxodG containing telomeric double-
stranded oligonucleotide substrates with or without a 3’-overhang, namely telomeric-
overhang-1 (TOH1) and telomeric-duplex-4 (TD4). TOH1 has 39-mer duplex region 
followed by an 18 bp 3’-overhang. The duplex region contains an 8-oxodG lesion 12 bp 
away from the opening of the single-stranded 3’-overhang (Table 5.1, Figure 5.2). α-
hOGG1 was incubated with 0.5 nM of substrates in serial dilutions and the percentage of 
incision products were measured between two substrates. When TOH1 was incubated 
with 16 nM enzyme, the incision product was visible and increased up to 60% with 256 
nM enzyme (Figure 5.6A, lanes 2-7). The TD4 substrate showed a similar trend upon the 
same enzymatic treatment (Figure 5.6A, lanes 9-14). This result suggests that α-hOGG1 
can efficiently excise a guanine lesion that is distant from 3’-overhang.  
The junction between the single-stranded 3’-overhang and the duplex DNA 
appears to be essential in preserving the integrity of the 3’-overhang, hence the formation 
of the t-loop (29,33). TRF2 binds to the junction sites, where it is essential in t-loop 
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Figure 5.6 – The position of 8-oxodG base lesion affects α-hOGG1 incision activity on telomeric substrates with 3’ overhang.  
(A) Substrates (0.5 nM) were incubated alone (lanes 1 and 8) or together with increasing concentrations of α -hOGG1 (8, 16, 32, 64, 128, or 256 nM, lanes 2-7 
and 9-14). The incision activity on telomeric duplex substrate with 3’-overhang was comparable to duplex without 3’ over-hang. (B) Substrates (0.5 nM) were 
incubated alone (lanes 1 and 7) or together with increasing concentrations of OGG1 (16, 32, 64, 128, or 256 nM, lanes 2-6 and 8-12). 8-oxodG modification near 
opening of 3’-overhang greatly reduced the α -hOGG1’s incision activity. The percentage cut was plotted against α -hOGG1 concentrations. Values and error bars 
represent the mean and SE from three independent experiments. 
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formation (33). Since oxidative guanine damage can disrupt the binding by telomere 
repeat binding factors (112), the repair of oxidative guanine lesions at the junction sites is 
critical for telomere capping. We thus examined if 8-oxodG modification at the 
ssDNA/dsDNA junction could be efficiently removed by α-hOGG1 using TOH2 and 
TD5. TOH2 has 8-oxodG modification one base pair away from the first base of the 3’-
overhang. TD5 has the same sequence as TOH2 except with complimentary strand 
extended the 3’-overhang region to complete the duplex.  Interestingly, the α-hOGG1 
incision activity was greatly reduced on the overhang substrate TOH2. 16 nM of α-
hOGG1 was able to initiate the incision (35% product) on the duplex substrate TD5, 
whereas 64 nM of enzyme was required to initiate product formation (only 5% product) 
from the overhang substrate TOH2 (Figure 5.6B, lanes 2-6 and 8-12). The difference in 
the percentage of incision products was as high as ~15-fold. Together, these results 
suggest that the telomeric structure (3’-overhang) has differential effects on the in vitro 
incision activity of α-hOGG1, which is dependent on the position of the guanine base 
lesions. 
 
Telomeric D-loop formation does not impair α-hOGG1 incision activity 
To further examine the effects of  telomeric structures on oxidative damage repair 
at telomeres, we examined α-hOGG1 incision activity on in vitro assembled D-loop 
structures DL1 & DL2 (Table 5.1, Figure 5.7). These substrates consist of a bubble 
structure with two 30 bp duplex arms separated by a 33 nt ssDNA melted region, one 
strand of which is annealed to an invading ssDNA. The melted region and the invading 
 




Figure 5.7 – Representation of assembled of telomeric D-loop substrate. X in bold indicates 8-oxodG modifications.  
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ssDNA carry four telomeric repeats, such that the DNA substrate mimics a telomeric D-
loop. The invading telomeric strand contains a 8-oxodG lesion in place of the middle 
guanine of the first (DL1) or the last (DL2) of four telomeric repeats (263).  α-hOGG1 
was incubated in serial dilutions with 0.5 nM of substrates and the incision activity was 
compared between one of the D-loop substrates (DL1) and the double-stranded telomeric 
substrate TD1. α-hOGG1 excised the lesion from the in vitro assembled D-loop substrate 
DL1 slightly more efficiently than the duplex substrate TD1 using higher concentrations 
(>64 nM) of α-hOGG1 (Figure 5.8A, lanes 1-6 and 7-12). We also tested the effect of the 
position of the 8-oxodG lesion on α-hOGG1 incision activity on the damaged telomeric 
D-loop substrate. Similarly to the observation on double-stranded oligonucleotides with 
3’-overhang, 8-oxodG positioned closer to 5’ site (DL2) was excised slightly more 
efficiently (Figure 5.8B, lanes 1-6 and 7-12) than the one close to 3’-end (DL1). 
Collectively, these results suggest that a telomeric D-loop structure does not impair α-
hOGG1 incision activity and that the position of the 8-oxodG lesion may dictate the 
enzymatic efficiency on oxidatively damaged telomeric D-loops in vitro. 
 
An 8-oxodG near a telomeric fork ssDNA/dsDNA junction reduces α-hOGG1 
incision activity 
The binding of telomere repeat factors to telomere DNA is sequence specific 
(15,25,265). Unrepaired 8-oxodG can be highly mutagenic after DNA replication (122) 
and may therefore be detrimental to the binding of telomere repeat binding factors. Thus, 
we examined if 8-oxodG in a telomeric replication fork context can be efficiently incised 
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Figure 5.8 – α-hOGG1 incision activity is influenced by position of 8-oxodG base lesion on d-loop substrates.  
Substrates (0.5 nM) were incubated alone (lanes 1 and 7) or together with increasing concentrations of OGG1 (16, 32, 64, 128, or 256 nM, lanes 2-6 and 8-12). 
(A) In vitro assembled d-loop substrate was excised slightly more efficiently than double-stranded telomeric substrate. (B) The d-loop substrate with 8-oxodG 
modification closer to 5’ end was excised slightly more efficiently than the D-loop substrate with 8-oxodG modification closer to 3’ end. The percentage cut was 
plotted against α -hOGG1 concentrations. Values and error bars represent the mean and SE from three independent experiments.  
 
- 142 - 
by α-hOGG1. Since the position of the 8-oxodG may dictate α-hOGG1 incision activity, 
two 8-oxodG containing telomeric fork substrates, TF1 and TF2, were constructed for 
this purpose. TF1 contains 8-oxodG 12 bp away from the fork region (resembles an 
unreplicated region), while TF2 has 8-oxodG next to the fork ssDNA/dsDNA junction 
(Table 5.1, Figure 5.2). α-hOGG1 was incubated in serial dilutions with 0.5 nM substrate 
and the incision activity was compared between telomeric fork substrates and its 
corresponding double-stranded telomeric substrates (TF1 & TD4, and TF2 & TD5, 
respectively). By using substrates TF1 and TD4, the incision products were visible after 
addition of 16 nM enzyme and increased up to 60% with 256 nM enzyme at similar rates 
in both substrates (Figure 5.9A, lanes 1-7 and 8-14). However, α-hOGG1 was unable to 
efficiently excise 8-oxodG from the other fork substrate TF2 in which the lesion is next 
to the fork region. While 64 nM of the enzyme was able to generate more than 50% 
incision product from a similar telomeric duplex substrate (TD5), a large excess (256 
nM) of enzyme was required to generate only about 20% incision product using the 
telomeric fork TF2 (Figure 5.9B, lanes 1-7 and 8-14). The difference in percentage of 
incision products was as high as ~16-fold. Together, these results imply that α-hOGG1 
can efficiently excise a guanine lesion that is distant from the telomeric fork, but its 
ability to excise a telomeric 8-oxodG lesion next to a fork ssDNA/dsDNA junction is 








Figure 5.9 – The telomeric substrate with 8-oxodG base lesion near fork-opening greatly affects α-hOGG1 incision activity.  
Substrates (0.5 nM) were incubated alone (lanes 1 and 8) or together with increasing concentrations of α -hOGG1 (8, 16, 32, 64, 128, or 256 nM, lanes 2-7 and 9-
14). (A) 8-oxodG modification away from fork-opening did not affect α -hOGG1’s incision activity. (B) 8-oxodG modification near the fork-opening significantly 
reduced α -hOGG1’s incision activity. The percentage cut was plotted against α -hOGG1 concentrations. Values and error bars represent the mean and SE from 
three independent experiments.  
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Telomere binding proteins do not impede α-hOGG1 incision activity on telomeric 
duplex substrates 
Shelterin protein complex functions to mask the ends of linear chromosomes from 
DNA repair at telomeres (3). Additionally, over-expression of shelterin protein TRF2 can 
lead to inefficient SSB repair at telomeres (266). We hypothesized that shelterin proteins 
such as TRF1 and TRF2 would affect α-hOGG1 incision activity, when bound to 
telomeres. To evaluate the effect of shelterin proteins on α-hOGG1 incision activity, we 
examined activity on a double-stranded telomeric oligonucleotide substrate bound by 
either TRF1 or TRF2. To ensure that TRF1 is bound to the substrate with 8-oxodG 
modification in one of telomeric repeats, EMSA was performed using the same 
experimental conditions as for α-hOGG1 incision assay. Under these experimental 
conditions, purified TRF1 was detectable at telomeric substrate TD1 (data not shown) 
and TRF1 alone did not excise the substrate (Figure 5.10, lanes 9-13). When the substrate 
TD1 was pre-incubated with 16 nM purified TRF1 prior to α-hOGG1 (4 nM) treatment, 
the incision activity did not change compared to α-hOGG1 treatment alone (Figure 5.10, 
lanes 2 and 3). However, with gradual increase in TRF1 concentration, a slight increase 
in incision activity was observed in large excess (256 nM) of TRF1 (Figure 5.10, lanes 3-
8). To examine if this minor stimulation was dependent on TRF1’s ability to bind to 
oligonucleotide substrate containing telomeric DNA repeats, the same assay was 
performed on oligonucleotide substrates containing non-telomeric DNA repeats. 
Interestingly, we found that in presence of a large excess of TRF1, it can also weakly 
enhance α-hOGG1 glycosylase activity on non-telomeric substrates NTD1 and NTD2 
 




Figure 5.10 – The shelterin protein TRF1 does not greatly affect α-hOGG1 incision activity. 
Substrate (0.2 nM) was incubated alone (lane 1) or together with fixed amount of α -hOGG1 (4 nM, lanes 2-
8) and increasing concentrations of TRF1 (16, 32, 64, 128, or 256 nM, lanes 4-8 and 9-13). The percentage 
of incision products was plotted against TRF1 concentrations. Values and error bars represent the mean and 
SE from three independent experiments. 
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(data not shown), even though EMSA showed no binding of TRF1 to these substrates 
(data not shown). These data indicate that TRF1 binding does not have any effect on the 
activity of α-hOGG1.  We also tested if TRF2 had any effect on α-hOGG1 incision 
activity. Under the same experimental condition, TRF2 did not enhance α-hOGG1 
incision activity (Figure 5.11). These results indicate that large excess of TRF1, but not 
TRF2 can weakly stimulate α-hOGG1 incision activity on 8-oxodG containing 
oligonucleotide substrates, which was independent of TRF1’s ability to bind to the 
substrates. Together, our results suggest that α-hOGG1 is able to proficiently excise 8-
oxodG containing oligonucleotide substrates bound by telomere binding proteins in vitro.  
 
 




Figure 5.11 – TRF1 and not TRF2 moderately stimulate α-hOGG1 glycosylase activity.  
The percentage of incised products was plotted against α -hOGG1concentrations. 
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5.4 Discussion 
Due to its low oxidation potential, guanine succumbs to oxidation more than other 
DNA nucleobases (122,267,268). Additionally, studies indicate that 5‘ guanine of stacked 
GG and GGG sequences oxidize more easily than a lone guanine in DNA and that the 
5‘ guanine of GGG oxidizes more easily than the 5‘ guanine of GG (246,267,269). 
Telomere tracks consisting of GGG repeats may greatly increase this oxidation potential 
when compared to the other repeats with single G. In fact, human cells with long 
telomeres show increased sensitivity to hydrogen peroxide, but not to etoposide and 
bleomycin, supporting that telomeres are particularly vulnerable to oxidative damage 
(102). Here, we provide evidence that telomeric DNA is prone to oxidative guanine 
damage than minisatellite TG repeats in vivo. In agreement with our findings, previous 
oligonucleotide-based in vitro studies yielded similar results (106-108). Furthermore, in 
vitro exposure to oxidants on naked DNA displayed more Fpg-sensitive lesions in 
telomeres than minisatellite TG repeats. These observations suggest that the nature of 
TTAGGG in telomeres could be the primary driving force behind the preferential 
accumulation of oxidative guanine damage.  
Alternatively, telomere unique factors i.e. telomere-specific binding proteins, 
repeat sequences, and telomere secondary structures may influence guanine oxidation 
and/or repair at telomeres and in turn promote accumulation of oxidative guanine damage 
in telomeres. The fact that there is preferential guanine damage in telomere than non-
telomeric G-rich DNA and that UV-induced damage at telomeres was more pronounced 
compared to other genomic regions (236) suggest that DNA damage repair at telomeres is 
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less effective than in non-telomeric regions. In this study, we demonstrated that acute 
oxidant exposure causes high incidences of Fpg-sensitive sites in TG minisatellite and 
telomeric DNA fragments. However, Fpg-sensitive sites were nearly undetectable in TG 
minisatellites whereas these lesions persist at higher level in telomeres after 6 hours of 
recovery time. These observations suggest that repair of oxidative DNA damage may be 
less effective in telomeres in vivo, which could be influenced by telomere associated 
unique factors. 
α-hOGG1 is the primary glycosylase that removes 8-oxodG and me-Fapy with 
comparable efficiencies (141). Here, we evaluated telomere special factors (i.e., telomeric 
DNA repeat sequences, telomeric structures or telomere binding proteins) in influencing 
telomeric 8-oxodG removal by α-hOGG1. Initially, we investigated the impact of 
telomere repeat sequences in the α-hOGG1 incision activity. The sequence-dependent 
repair efficiency of α-hOGG1 has been reported, even though the study was conducted 
using me-Fapy as the substrate (141). It shows that α-hOGG1 incision activity on me-
Fapy was affected by the flanking sequences, with preference for 5’-(C/G)me-FapyC-3’. 
Nevertheless, α-hOGG1 incision activities on the telomeric and non-telomeric sequence 
contexts were similar.  
Previous studies demonstrate that oxidant exposure increases 8-oxodG content in 
the DNA fragment containing the telomeric sequences in vitro. In addition, more than 
one guanine in GGG of telomeric are oxidized (107,108). In this study, we demonstrated 
that substrates containing single and triple 8-oxodG lesions were excised equally by α-
hOGG1, showing no preference for either substrate. In addition, α-hOGG1 appears to 
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favor incising middle and 5’ 8-oxodG in GGG of telomeric DNA. In agreement with our 
findings, a previous report showed that α-hOGG1 preferred to excise 5’ me-Fapy on 
guanine doublets (141). It is possible that this preference could be a structurally 
conserved mechanism since oxidative damage induces 8-oxodG preferentially at the 5’ 
site of 5’-GGG-3’ sequence (107,108). It has been proposed that optimal DNA twisting 
plays an important role in lesion recognition (140). Flipping middle 8-oxodG by OGG1 
may be preferred since DNA torsional rigidity near the 8-oxodG greatly affects the α-
hOGG1 recognition and incision activity (140,270). In addition, it is possible that α-
hOGG1 may prefer to work in a certain direction to favor 5’ site incision since α-hOGG1 
works in a processive mode (140). For instance, single-strand-breaks (SSBs) toward 3’ of 
α-hOGG1 catalytic pocket hinders its incision activity, whereas no adverse effect is 
observed when SSB  is situated at the 5’ of α-hOGG1 catalytic pocket (138,139). α-
hOGG1 may therefore work in 3’ to 5’ direction to accommodate for this possible pitfall, 
which could consequently result in more excision products towards 5’ site 8-oxodG. α-
hOGG1’s preference in excising 5’- and middle 8-oxodG in GGG of telomeric DNA 
repeats may also explain the frequent appearance of SSBs at 5’ guanine in the telomere 
repeats after oxidative stress (107,108). 
One of the unique structural features that shape telomeres is the 3’-overhang, also 
known as the G-rich overhang. It is important in the t-loop formation and plays a vital 
part in the initiation process (3). Here, we demonstrated that α-hOGG1 was unable to 
efficiently excise 8-oxodG near a 3’ overhang opening. Previous studies have shown that 
an opposing abasic site greatly reduced α-hOGG1 incision activity (137). In addition, a 
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SSB 3’ of the catalytic pocket hinders α-hOGG1 glycosylase activity (138,139). An 8-
oxodG near the 3’ overhang completely lacks the complementary strand, and it is 
therefore possible that α-hOGG1 is significantly compromised in repairing oxidative 
damages in the presence of strand breaks near its active site pocket. If these base lesions 
are not repaired, this may pose a problem since it has been previously shown that 8-
oxodG perturbs TRF1 and TRF2 from binding to telomeric DNA repeats (112), and the 
junction between the telomeric duplex and the 3’ opening plays an important role in 
telomere length maintenance. For instance, TRF2 is implicated in t-loop formation by 
binding to the junction site (15,23). Disruption of TRF2 binding to the junction region 
can lead to truncation of 3’ overhang, telomere uncapping, and telomere fusion mediated 
by nonhomologous end-joining (29,30,33). 
The t-loop helps to protect the ends of linear chromosome from being recognized 
as broken DNA (3). The d-loop, as a result of t-loop formation, is the secondary structure 
formed when the tip of G-rich strand binds to C-rich strand via strand invasion (3). Our 
data showed that 8-oxodG in a d-loop can be excised by α-hOGG1 with differential 
efficiency, depending upon its position. Similarly to the observation on 8-oxodG 
containing oligonucleotides with 3’ overhang, embedded 8-oxodG in the d-loop was less 
effectively excised by α-hOGG1 when it was close to the terminal end. Although α-
hOGG1 is not active on single-stranded substrates, it may excise 8-oxodG when the 3’ 
overhang is formed in a d-loop with double-stranded telomere DNA. This incision 
activity may play an important part in telomere length maintenance since it was 
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previously shown that 8-oxodG at single telomeric nucleotides disrupt telomerase activity 
(111).  
Efficient repair prior to DNA replication is critical in preventing 8-oxodG 
mutagenesis (122). In this study, we showed that 8-oxodG at telomeric fork opening led 
to inefficient α-hOGG1 excision activity. In agreement with this finding, a previous study 
shows that α-hOGG1 can excise fork substrates and increase the incision efficiencies by 
positioning the 8-oxodG up to 3 nucleotides away from the opening (139). The fact that a 
SSB 3’ of the catalytic pocket in α-hOGG1 hinders its incision activity also supports this 
notion (138). Oxidative guanine damage, 8-oxodG, disrupts binding of shelterin proteins 
(112), which has been shown to be involved for proper replication at telomeres (221,222). 
It is possible that oxidative DNA damage can have undesired consequences during 
replication if not readily repaired. Furthermore, adenine will be incorrectly incorporated 
if 8-oxodG is not promptly repaired, (122), which can impede the binding of TRF1 and 
TRF2 to telomeres, consequently affecting their regulation on telomere length regulation 
and telomere capping (112).  
Shelterin caps the ends of chromosomes to prevent from spurious DNA repair. A 
previous study has shown that over-expression of TRF2 leads to inefficient SSB repair at 
telomeres (266). It is possible that TRF1 and TRF2 may hinder the access of BER 
proteins to repair base lesions. However, α-hOGG1 can efficiently excise 8-oxodG in the 
telomere oligonucleotides pre-bound with TRF1 or TRF2, suggesting that shelterin does 
not inhibit the BER function in telomeres. Interestingly, TRF1, but not TRF2, mildly 
stimulated α-hOGG1 incision activity. In addition, this stimulation was observed on DNA 
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substrates that are unable to bind TRF1; excluding the possibility that TRF1 may recruit 
α-hOGG1 to the damaged sites. It is still unclear how TRF1 weakly promotes α-hOGG1 
glycosylase activity at telomere.  
In this study, we demonstrate that telomeres are prone to the accumulation of 
oxidative guanine lesions and 8-oxodG removal by OGG1 could be affected by its 
position in different telomere structures (e.g., fork-opening, 3’- overhang, and d-loop). 
Telomere shortening has been linked to human aging, bone marrow failure syndromes 
and cancer development (271), and oxidative DNA damage is a contributing factor (272). 
We recently demonstrated that telomere shortening occurs in Ogg1 deficient mice 
experiencing high degrees of oxidative stress (262). Telomere guanine damage associated 
telomere attrition may thus contribute to premature aging and cancer formation. 
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